University of Connecticut

OpenCommons@UConn
Master's Theses

University of Connecticut Graduate School

8-22-2016

Chemosensory Function in Chronic Smokers:
Findings from NHANES 2011-2014 and an ECigarette Intervention
Sarah-Grace Glennon
University of Connecticut - Storrs, gglennon203@gmail.com

Recommended Citation
Glennon, Sarah-Grace, "Chemosensory Function in Chronic Smokers: Findings from NHANES 2011-2014 and an E-Cigarette
Intervention" (2016). Master's Theses. 972.
https://opencommons.uconn.edu/gs_theses/972

This work is brought to you for free and open access by the University of Connecticut Graduate School at OpenCommons@UConn. It has been
accepted for inclusion in Master's Theses by an authorized administrator of OpenCommons@UConn. For more information, please contact
opencommons@uconn.edu.

Chemosensory Function in Chronic Smokers: Findings from
NHANES 2011-2014 and
an E-Cigarette Intervention

Sarah-Grace Glennon, R.D.
B.S., University of Connecticut, 2014

A Thesis
Submitted in Partial Fulfillment of the
Requirements for the Degree of Masters of Science
At the University of Connecticut
2016

i

APPROVAL PAGE
Masters of Science Thesis
Chemosensory Function in Chronic Smokers: Findings from
NHANES 2011-2014 and
an E-Cigarette Intervention

Presented by
Sarah-Grace Glennon, RD

Major Advisor________________________________________________________________
Valerie Duffy
Associate Advisor_____________________________________________________________
Michael Copenhaver
Associate Advisor_____________________________________________________________
Bruce Blanchard
Associate Advisor_____________________________________________________________
Mark Litt
University of Connecticut 2016

ii

ACKNOWLEDGEMENTS
I would like to thank my advisory committee for their help and support throughout the process of
completing my Master’s Thesis. I have been lucky to work with four talented individuals who
are not only great teachers but also great researchers.
I would first like to thank my Major Advisor Dr Valerie Duffy. Her dedication to helping me
succeed, challenging me, and teaching me to be a better researcher and scientist has been
instrumental in my success throughout this process. She has been a great role model, and I have
learned an immeasurable amount from her. I admire her for her dedication to science, teaching,
as well as her family.
I would also like to thank my associate advisors for their guidance during my thesis work. Dr.
Copenhaver, Dr. Blanchard, and Dr. Litt have provided their own unique insights and expertise
to help me grow and mold my thesis work into the best possible product.
I would like to recognize the research team on the Electronic Cigarette Study at the UCONN
Health Center. Diane Wilson and Eileen Leonard welcomed me to their research team and have
provided constant support through my graduate studies. In addition, I would like to thank Shristi
Rawal and Dr. Tania Huedo-Medina for their support and teaching of their statistical and
research expertise.
Finally, I would like to thank my friends and family. My fellow students, Jenn Buden and Kayla
Vosburgh, have been my constant support system throughout all of graduate school. I would like
to thank my mom, dad, brother and sister for always sending words of encouragement, and my
boyfriend Pat for his constant love and support. I would not be where I am today without all of
these important people.

iii

TABLE OF CONTENTS
Title Page ………………………………………………………………………………….…. i
Approval Page………………………………………………………………………………… ii
Acknowledgements…………………………………………………………………………… iii
Definitions of Variables………………………………………………………………………. vi
CHAPTER ONE……………………………………………………………………………... 1
Introduction
1.1 Overview…………………………………………………………………………... 1
1.2 Background………………………………………………………………………… 1
1.3 Purpose…………………………………………………………………………….. 5
1.4 Specific Aims……………………………………………………………………… 5
1.5 Hypotheses………………………………………………………………………… 6
1.6 Significance……………………………………………………………………….. 7
1.7 References…………………………………………………………………………. 8
CHAPTER TWO.................................................................................................................... 13
Cigarette Smoking’s Association with Self-reported Olfactory Alterations: Analysis of the
2011-2014 NHANES.
2.1 Abstract…………………………………………………………………………… 13
2.2 Introduction……………………………………………………………………….. 14
2.3 Methods…………………………………………………………………………… 17
2.3.1 Data Source and Participants……………………………………………. 17
2.3.2 Measures………………………………………………………………… 17
2.3.3 Data Analysis……………………………………………………………. 21
2.4 Results…………………………………………………………………………….. 23
2.4.1 Risk factors associated with olfactory alteration examined by univariate
analysis………………………………………………………………………... 24
2.4.2 Examination of smoking status as a risk factor for olfactory alteration by
multivariable analysis………………………………………………………... 27
2.4.3 Examination of the indirect relationship with olfactory alteration through
mediation modeling…………………………………………………………… 30
2.5 Discussion…………………………………………………………………….….. 31
iv

2.6 Conclusion……………………………………………………………………….. 37
2.7 References……………………………………………………………………….. 38
CHAPTER THREE………………………………………………………………………… 43
Heightened olfactory dysfunction and oral irritation among chronic smokers and heightened
propylthiouracil (PROP) bitterness among menthol smokers.
3.1 Abstract…………………………………………………………………….…… 43
3.2 Introduction…………………………………………………………………….. 44
3.3 Methods……………………………………………………………………..….. 47
3.3.1 Study Design and Participants………………………………………... 47
3.3.2 Procedure and Measures……………………………………………... 48
3.3.3 Data Analysis………………………………………………….……… 50
3.4 Results…………………………………………………………………………. 51
3.4.1 Self-reported olfactory and taste alteration………………………….. 53
3.4.2 Measured olfactory function…………………………………………. 53
3.4.3 Measured taste function…………………………………………….... 55
3.4.4 Taste function between menthol and non-menthol smokers…………. 56
3.4.5 Retronasal function…………………………………………………… 57
3.4.6 Preferred electronic cigarette flavor…………………………….……. 58
3.5 Discussion………………………………………………………………………. 59
3.6 Conclusion………………………………………………………………………. 63
3.7 References………………………………………………………………………. 64
CHAPTER FOUR…………………………………………………………………….…… 70
Conclusions
4.1 Important Findings…………………………………………………………........ 70
4.2 Implications for Future Research……………………………………………….. 72
Supplemental Material…………………………………………………………………….. 74

v

DEFINITION OF VARIABLES
The following variables were measured and evaluated for this research. The definition for each
variable is provided; differences between chapter two and three on the variable are noted.

Demographic Characteristics
The following variables were measured by self-report through survey questionnaires.
Age and Gender: Participants self-reported age in years and gender as male or female.
Race/Ethnicity: Race was classified as Mexican American, Other Hispanic, Non-Hispanic
white, Non-Hispanic black, Non-Hispanic Asian, or other non-Hispanic/Multirace based on the
National Health and Nutrition Examination (NHANES) categories1 for chapter two. For chapter
three, race was classified as American Indian, Asian, Hawaiian, Black, White, or Multi-Race.
Education: Participants were asked to mark their highest level of educational attainment based
on grade levels and college education. Education level was dichotomized to below high school,
or high school and above.
Marital Status: Participants self-reported being married, living with a partner, divorced,
widowed, separated, or never married (single). Marital status was dichotomized to
married/cohabitating, or not (widowed, divorced, separated, or never married/single).
Income Status: Participants were asked to report their annual household/family income either by
$5,000 increments or $10,000 increments from zero dollars to $100,000 or above. For chapter
two, this information was viewed as an income to poverty ratio based on The Department of
Health and Human Services (HHS) poverty guidelines2. These are yearly defined guidelines used
to determine eligibility for federal supplemental programs such as SNAP. A ratio of ≤ 1 is
considered below the poverty line, and >1 is above the poverty line. For chapter three it was
viewed in dollar amount.
vi

Health History Characteristics
The following variables were measured by self-report through survey questionnaires to assess the
presence of risk factors for chemosensory issues. Noted is if each variable is used in both, or one
study.
Self-rated health status: Participants were asked to self-rate their overall general health as
excellent, very good, good, fair, or poor as part of the NHANES questionnaires3. Health status
was dichotomized to excellent/very good/good vs. fair/poor. This variable was not assessed in
chapter three.
Sinonasal problems: Participants were asked if they experienced either frequent nasal
congestion, or a cold/flu that lasted longer than a month during the past year. The variable was
dichotomized to presence/absence of these sinonasal issues in both studies.
Xerostomia: Participants were asked if they experience persistent dry mouth or not enough
saliva during the past year (yes/no). This variable was used in both studies.
Serious head or face injury: Participants were asked if they ever experienced a broken nose or
serious face injury, or lost consciousness due to a head injury. This was dichotomized to yes/no
in both studies.
Tonsillectomy: Participants were asked if they ever had their tonsils removed, either as an adult
or as a child (yes/no). This variable was used in both chapter two and three.
Frequent Ear infections: Participants were asked if they have ever had three or more ear
infections (yes/no). They were asked to think back to when they were a child and include these
instances as well. This variable was not used in chapter three.
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Alcohol consumption: Participants were asked about their alcohol consumption as part of the
examination section of NHANES4. A heavy drinker was classified as reporting having 4/5 drinks
on almost every day, either formerly or currently. This variable was not used in chapter three.
Body Mass Index (BMI): Body Mass index was calculated based on participant’s self reported
height and weight. The equation is:

BMI was classified with the CDC definitions for underweight, normal weight, overweight, obese
grade I, obese grade II, and obese grade III5.

Cigarette Use
The following variables were measured by self-report and/or objective measure to assess current
and former cigarette smoking use.
Cigarette Smoker: In chapter two, participants were classified as never, current, or former
cigarette smokers based on self-reported use. A smoker was classified as ever smoking 100
cigarettes in their lifetime. In chapter three, an inclusion criterion for the study was smoking at
least ten cigarettes a day. Participants in both studies were asked to self-report average cigarettes
smoked per day as well as number of years they currently or previously smoked. Smokers were
further classified in chapter two based on the following measurements, which are described in
more detail in the methods section of chapter two:
Pack Years: Determined based on packs smoked/day * years smoked.
Time to first cigarette (TTFC): Based on self-reported time to first cigarette upon waking
in the morning. This is classified as within 30 minutes of waking, or after 30 minutes of
waking.
viii

Serum Cotinine Level: Blood serum cotinine level was measured through a blood draw.
Cotinine is a metabolite of nicotine used to measure recent cigarette use or exposure. A
value of less than 10 ng/mL or ≥ 10 ng/mL was used.
Menthol Status: In chapter three, smokers were further classified by menthol status. Responses
to brand of cigarette used classified participants as menthol or non-menthol smokers.
Preferred Electronic Cigarette Flavor: In chapter three, cigarette smokers trialed five
electronic cigarette flavors (Tobacco, menthol, cherry, chocolate, no flavor), rating the most
preferred flavor to least preferred flavor.

Chemosensory Function
The following variables were measured through survey questionnaires to assess self-rated
chemosensory function. In addition, measured variables of chemosensory function were used in
chapter three. Noted is if each variable is used in both, or one chapter.
Self-reported olfactory function: NHANES questions are formulated to assess self-rated
olfaction and taste function6 and used in both chapters. Participants were asked about perceived
smell problems within the past 12 months [yes/no], phantom odor sensations [yes/no], and
changes since age 25 in smell function [no change, better now, worse now]. Participants who
answered ‘yes’ to either of the first two questions or ‘worse now’ to the last question were
classified as having an olfactory alteration. This classification based on the three questions has
proved to have test-retest reliability7 with fair sensitivity and specificity when compared with a
single measure of olfactory function8.
Self-reported taste function: This variable was examined only in chapter three. Based on the
NHANES protocol, participants were asked about perceived problems in the past year, loss or
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change in function since age 25, for taste (salt, sweet, bitter, sour) and for flavor (chocolate,
vanilla or strawberry), as well as the presence of dysgeusia (taste things when nothing should be
there) 6. Participants who answered ‘yes’ to problems, or ‘worse now’ since age 25 were
classified as having a taste alteration.
general Labeled Magnitude Scale (gLMS): All sensory intensity ratings described below for
chapter three were made on the gLMS scale, which ranges from 0=nothing to 100=strongest
sensation of any kind, with intermediate labels of 6=barely detectable, 17=moderate, 35=strong,
and 53=very strong. This scale generalizes ratings to all sensations, and has shown consistency
with magnitude matching9, the gold standard for measuring perceived intensity.
Measured Olfactory Function: A sixteen-item odor identification and intensity rating task was
used to measure olfactory function. Participants were classified as anosmic/severe hyposmic (0-7
odors identified correctly), hypsomic (8-12 identified correctly) or having a normal sense of
smell (13-16 correctly identified). This was only examined in chapter three.
Measured Taste Function: Taste function was measured using the NHANES protocol10.
Participants sampled concentrated quinine hydrochloride (QHCl - 1mM) as well as concentrated
sodium chloride (NaCl - 1M and .32 M) drawn across the tongue tip and then sampled with the
whole mouth. Participants also reported the intensity of concentrated propylthiouracil (PROP - 1
and 3.2 mM) sampled with the whole mouth. Intensity ratings on the gLMS scale were compared
to a control group. This was measured only in chapter three.
Measured Retronasal Function: Retronasal function was measured using a jelly bean test and
included four jelly bean flavors (cherry, coffee, chocolate, and Tabasco®). Participants first rated
the sweetness/flavor intensity of the jelly bean with their nose plugged using the gLMS. Then
participants were told to unplug their nose and again rate the intensity of sweetness, flavor
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intensity, and level liking or disliking of the flavor on the gLMS. For the Tabasco® jelly beans,
participants also rated the intensity of the burn or irritation feeling with the nose unplugged.

xi

CHAPTER ONE
INTRODUCTION
1.1 Overview
There are a total of four chapters in this thesis. Chapter one serves as an introduction to the
research including specific aims and hypotheses. Chapter two and three report on studies of
cigarette smokers and their chemosensory abilities, focusing on olfaction and taste. Specifically,
chapter two reports on a secondary data analysis of the 2012-0214 National Health and Nutrition
Examination Survey Data (NHANES), testing the classification of smoking status used to
examine the association with self-reported olfactory alterations. Chapter three reports on baseline
data from an NIH-funded Electronic Cigarette Study being conducted at UConn Health. The
study population included male and female chronic cigarette smokers. Both chapters two and
three include an introduction, methods, results, discussion, conclusion, and references sections.
Chapter four serves as an overall conclusion, summarizing important results and implications for
future research.

1.2 Background
The chemosenses refer to the sense of smell and taste, two sensory systems relied on by
humans daily. The sense of smell functions through stimulation of the olfactory receptors by
volatile chemicals that pass through the nasal cavity or the nasopharynx. Once at the receptors,
olfactory neurons send the information to the central nervous system11. Odorants passing through
the nasopharynx play a key role in flavor perception via retronasal olfaction, linking taste and
smell together closely. Taste perception is mediated through taste buds located on the papillae of
the tongue, which contain taste receptors to identify each of the unique five tastes (salty, sweet,
-1-

sour, bitter, and unami). Multiple nerves contact taste receptors throughout the tongue and throat
to transfer taste information to the central nervous system11. Some differences in taste
perception, specifically bitter taste perception, are second to polymorphisms in up to 26 different
taste receptor genes, including the most studied TAS2R38 receptor gene 12. Additionally, taste
perception plays a key role in flavor preference13, including influencing differences among
smokers in choice of nicotine products, such as mentholated cigarettes or electronic cigarettes.
Disorders or alterations of these senses include depressed/loss of smell (hyposmia,
anosmia) and loss of taste (hypogeusia, ageusia), as well as distorted senses (parosmia) and
phantom sensations (phantosmia)11. Alteration of the olfactory and/or taste systems has been
linked to increased risk of exposure to hazards such as fire, fumes, or spoiled food14, as well as
poorer dietary quality15 and reduced quality of life16,17. Olfactory dysfunction is more common
than taste dysfunction, due to the redundancy of taste nerves that carry sensory information to the
central nervous system, yet individuals often have trouble distinguishing the two dysfunctions18.
Prevalence estimates of olfactory hyposmia/anosmia in population-based studies range from
3.8% to 19.1%10,19,20. Taste hypogeusia/ageusia prevalence estimates are much less, with one
study of a clinic population reporting 0.85% have true generalized taste loss21. Taste changes are
more likely to be localized to an area of taste nerve innervation, present as oral pain, and/or
flavor changes as result of an olfactory dysfunction22,23.
Main causes of olfactory and/or taste alteration include sinonasal conditions17, head
trauma24, neurogenerative diseases25, upper respiratory tract infections23, aging26,27, as well as
certain medications28,29. Alteration stems from changes or damage to receptors and the inability
to transmit signals to the central nervous system30,31. Treatments for olfactory alterations vary
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with the etiology, and include surgery or oral steroid use32-34. However, the outcome of many
treatments, as well as the long-term effectiveness, is still largely unclear32.
Because of the limitations of treatment for olfactory and taste alteration, prevention by
limiting exposure to modifiable risk factors is an important avenue to explore. One modifiable
risk factor that is a potential cause of olfactory and taste alteration is cigarette smoking. Cigarette
smoking has remained a serious issue in the United States for decades. In 2014, an estimated
16.8% of U.S adults were current smokers35. Of cigarettes sold in 2012, 31% were a mentholated
brand36 and used more frequently by younger individuals and minority groups, specifically
African Americans37. Although the detrimental effects of cigarette and tobacco use are well
known, approximately 480,000 individuals die every year from smoking, and an additional 16
million are living with a smoking related disease38 in the U.S. Additionally, 289 billion dollars
are lost in the U.S. due to cigarettes each year, including 133 billion dollars from direct medical
costs and over 156 billion dollars in lost productivity38. Healthy People 2020 has cigarette related
goals and objectives, including reducing illness and death related to tobacco and second hand
smoke exposure39.
The U.S. Surgeon General report of the 50 Year Progress on Health Consequences of
Smoking shows research over the decades has linked cigarette smoking to diseases in nearly all
organs of the body38. It is a direct cause of several cancers, including lung cancer40, and is
associated with heart disease41, chronic obstructive pulmonary disease42, diabetes43, rheumatoid
arthritis44, and a weakened immune system45. Smokers have also reported significantly lower
health-related quality of life compared to non-smokers. They are more likely to be heavy
drinkers, report depressive symptoms, be less physically active, and have poorer intake of fruits
and vegetables46.
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Conflicting results of cigarette smoking on olfactory/taste alterations have been found in
population and community-based studies. Several studies examining olfactory function in adults
via standardized measured identification tests found no association between smoking and
olfactory dysfunction19,47,48. However, other population-based studies have found smoking to be
a risk factor for olfactory dysfunction, ranging from examining this relationship in current
smokers and based on heaviness of smoking49,50. Similarly, studies have shown smokers to have
altered taste function, however the type of alteration found varies between studies. Studies have
found elevated taste sensations22 or greater taste thresholds51,52, as well as greater oral pain53
among smokers. Conversely, a study examining risk factors for taste alterations and increased
taste thresholds did not find an association with smoking54.
There are several potential reasons for the conflicting findings of the association between
cigarette smoking and olfactory/taste alterations, which points to the central aim of the current
thesis. First, the way smoking is measured between studies is inconsistent. Population-based
studies range in methods to characterize smoking as only current smokers to smoking heaviness
by reported number of cigarettes or pack years (packs/day * years smoked). Second, measured
function and single questions about olfactory/taste function do not always capture phantom
sensations, and perceived changes in function with age, which both effect chemosensory abilities
and must be accounted for. The NHANES 2012 results find smoking as a protective factor for
olfactory function, but characterize smoking only as reported current, former, or never.
Inconsistencies throughout population-based studies may account for varied findings in the
literature. Cigarette smoking may require sophisticated characterization, probing further than
current/former/never status. Additionally, olfactory and taste function must be measured
comprehensively, both by self-report and measured function, in order to fully understand the
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risks associated with altered functioning. Finally, cigarette smoking is associated with other
health behaviors and health risks, which also may combine to impact olfactory and taste
function. Cigarette smoking is linked to heavier alcohol use55, as well as more frequent sinus and
throat/mouth issues56-58. These unique and shared risks of being a cigarette smoker must be fully
examined to understand the relationship with olfactory and taste alterations.

1.3 Purpose
The purpose of this research is to utilize a nationally-representative sample as well as a
clinical sample of well-characterized cigarette smokers to improve the understanding of the
chronic smoking effects on self-reported and measured olfactory and taste function. First, we
assessed what measure of smoking in large population-based studies helped to best assess the
relationship between smoking status and self-reported olfactory alteration and additional risk
factors that contributed to the smoking-olfaction relationship, both directly and indirectly.
Measures of smoking that captured chronic use, heaviness, and nicotine dependence were tested.
Second, we aimed to assess olfactory and taste function of chronic smokers through objective
measures, and assessed differences compared to non-smokers to determine variation among
chronic smokers, specifically in regards to menthol status.

1.4 Specific Aims
1) To use the National Health and Nutrition Examination Survey (NHANES) 2011-2014
data to assess the direct and indirect relationship between cigarette smoking and selfreported olfactory alteration, testing different measures of smoking to determine the most
helpful measure/combination of measures.
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2) To use NHANES to assess what other olfactory-related risk factors and health behaviors
(e.g., heavy alcohol use) contribute to the relationship between smoking and self-reported
olfactory alteration.
3) To use a well characterized clinical sample of cigarette smokers to assess measured
olfactory and taste function and compare dysfunction rates to non-smokers and national
prevalence estimates.

4) To identify if the favorite flavor of electronic cigarettes of new electronic cigarette
smokers was associated with their chemosensory function or use of mentholated
cigarettes.

1.5 Hypotheses
1) Smoking is a risk factor for self-reported olfactory alteration, but the significance of
findings will be based on the measure of smoking used.
2) The most helpful measure of smoking to assess the relationship with self-reported
olfactory alteration will include markers of chronic use (pack years), dependence (time to
first cigarette), and biomarkers of heaviness (serum cotinine).
3) The combination of smoking and heavy drinking will increase the odds of a self-reported
olfactory alteration even greater than being a smoker alone.
4) An indirect relationship will also exist between chronic smoking/smoking and drinking
and self-reported olfactory alteration through known olfactory-related pathologies.
5) Measured olfactory dysfunction, along with self-reported alteration, will be greater in
chronic smokers, compared to general population estimates, and vary by menthol status.
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6) Measured taste function of chronic smokers will show more impairment compared to
non-smokers, and vary by menthol status.
7) Electronic cigarette flavor preference will vary by menthol status or PROP taster profile.
1.6 Significance
The effects of cigarette smoking and taste/olfactory alteration have a significant impact on
health, health care costs, and quality of life. The relationship between the two is still largely
unclear due to inconsistent measures, which highlights the importance of further exploration. The
significance of the research is first to provide insight into measures and characterization of
smoking to understand those at highest risk for chemosensory alteration. Secondly, the findings
from this thesis may provide information on additional benefits of smoking cessation as well as
information on prevention of chemosensory function through avoiding chronic smoking. Finally,
this research provides baseline chemosensory data of chronic smokers, allowing for examination
of changes in function with smoking cessation.
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CHAPTER TWO
Cigarette Smoking’s Association with Self-reported Olfactory Alterations: Analysis of the
2011-2014 NHANES.
2.1 Abstract
Background: Population-based studies show inconsistent effects of cigarette smoking on
olfactory function. We aimed to identify direct and indirect associations between measures of
smoking exposure/dependence and altered olfaction in a nationally-representative sample of
adults. Methods: NHANES 2011-2014 (n=7,418) participants (mean age=57.8±12.2 years) selfreported olfaction and related health and demographic risks. Affirmative answers to three
questions defined altered olfaction (olfactory problems in past year, worse ability since age 25,
phantosmia). Smoking (never, former, current) was self-reported by chronicity (pack years, PY)
and dependency (time to first cigarette upon waking), and measured by serum cotinine.
Associations were tested with logistic regression, reporting odds ratios (OR) and 95% confidence
intervals (CI), and by mediation models. Results: Estimated prevalence of altered olfaction was
22.3% and showed age-related increases. Nearly half of the sample was former/current smokers
(47.4%). Controlling for olfactory-related risks, ≥10 PY smokers (current and former) had
significantly greater odds of altered olfaction versus never smokers [OR 1.36, CI: 1.06-1.74].
Current smoking with ≥10 PY failed to show greater odds of altered olfaction unless they
smoked within 30 minutes of waking [OR 1.41, CI: 1.01-1.99]. Light smokers (≤10 PY smokers)
did not show increased odds versus never smokers. Current smokers who also were heavy
drinkers (≥4 drinks/day) had greatest risk for altered olfaction (OR 1.96, CI: 1.20-3.19).
Olfactory-related pathologies (sinonasal problems, serious head injury, tonsillectomy,
xerostomia) partially-mediated the association between smoking and altered olfaction.
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Conclusion: Chronic cigarette smoking was associated with increased risk of self-reported
olfactory alterations, directly and indirectly via olfactory-related pathologies.

2.2 Introduction
According to the National Health and Nutrition Examination Survey (NHANES) 20112012, olfactory dysfunction is a prevalent problem, affecting nearly 13%1 of U.S adults ≥40
years of age based on performance on odor identification and 23%2 by self-report. Olfactory
dysfunction can range from partial (hyposmia) to complete (anosmia) loss, as well as alterations
perceived with age and phantom olfactory sensations2. Olfactory dysfunction may result from
changes to the olfactory receptors, inability of odors to reach and bind these receptors,
interrupted transmission of odors from the periphery to the central olfactory systems, or inability
to correctly identify and label odors3. As shown in clinical and population-based studies2,4-7,
common causes of olfactory dysfunction include frequent sinonasal problems8, trauma to the
head or face9, exposure to certain chemicals10, medications11, neurodegenerative disorders12, and
advanced age13. Individuals with olfactory dysfunction have greater risk of hazardous exposure
related to depressed ability to detect warning signs of fire, fumes, leaking gas, or spoiled foods14.
They can suffer from poorer dietary quality and nutritional status15,16, as well as reduced quality
of life17. Healthy People 2020 has added chemosensory disorder-related goals, including
increasing the proportion of adults who seek diagnosis and treatment for these disorders18. With
growing attention to olfactory function, screening, assessment and treatment options should be
expanded (e.g.19-22).
Olfactory dysfunction could be prevented by limiting modifiable risk factors. One
potential modifiable risk factor is cigarette smoking. In animal models, chronic exposure to
aqueous cigarette smoke decreases functional olfactory receptor neurons23. However, these
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findings have not been consistently generalized to large community and population based
studies. Baseline results from the Epidemiology of Hearing Loss Study indicated that current
smokers (relative to former and never smokers) had greater odds of olfactory dysfunction by
odor identification task 4, yet the 5-year follow-up found no significant association between
baseline smoking status and incidence of olfactory dysfunction24. A cross-sectional populationbased study of 1,300 Swedish adults found no association between measured odor identification
ability and cigarette smoking, whether defined as current smoking, heavy smoking, or pack
years25. Yet a cross-sectional population based study in Spain (n=9,348) utilizing selfadministered odor identification task and self-reported function, found that former or current
smoking was a mild protective factor for olfactory function5. Conversely, a population-based
study in Germany of 1,312 individuals found current smoking to be a risk factor for measured
olfactory dysfunction, with a dose-response relationship between cigarettes/day smoked and
frequency of impairment26. Similarly, a dose-response relationship was reported between
chronic smoking and odor impairment in a community-based study of 638 adults 27, yet the
combined effects of other olfactory-related risk factors on this association was not tested. A
recent clinical study also identified greater levels of olfactory dysfunction in chronic smokers
(thoroughly characterized for smoking behaviors) than that found in a nationally-representative
sample of U.S. adults 28.
Long-term cigarette exposure also may have an indirect effect on olfactory function
through other known risk factors for dysfunction including upper respiratory track infections29,
sinonasal problems30,31, and dry mouth (xerostomia)32. Smokers may be more susceptible to
developing viral respiratory colds 33. A comprehensive review also found that smoking was
associated with acute and chronic rhinitis and increased nasal inflammation34. Additional studies
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have found smokers more likely to experience xerostomia35, 36. These same risk factors
associated with increased risk of olfactory alteration in NHANES 2011-2012. Significant risk
factors for self-reported olfactory alteration were persistent cold/flu, persistent xerostomia,
frequent nasal congestion, and history of head injury as well as heavy alcohol consumption2.
Greater alcohol consumption has been noted among smokers 37. Excessive alcohol consumption
has been linked to depressed olfactory function measured by odor identification38 and/or odor
discrimination39,40, and dysfunction has been noted among those with Korsakoff Syndrome (a
neurological complication of alcohol dependence)41.
Using the NHANES 2011-2014 data, the goal of the present study was to examine the
independent and joint effects of smoking status and other olfactory-related risk factors on selfreported olfactory alteration in a nationally-representative sample of U.S adults 40 years and
older. The majority of studies to date have examined only self-reported current, never, or past
smoking. Here, we examined measures of self-reported smoking exposure including chronicity
(duration and amount smoked captured in pack years), as well as time to first cigarette of the day
(TTFC), which serves as a proxy for nicotine dependence that links with negative health
outcomes42,43. Additionally, we defined current smoking (at the time of the NHANES
assessment) by serum cotinine, the main metabolite of nicotine, which is regarded as the best
biomarker of smoking status and exposure44. We hypothesized that defining smoking status by
chronicity, dependence and a nicotine biomarker would strengthen its association with selfreported olfactory alteration. We also hypothesized a synergistic effect of dependent smoking
and heavy alcohol consumption on olfactory alteration. Finally, we hypothesized that smoking
would have an indirect effect on self-reported olfactory alteration through other olfactory-related
pathologies (e.g., sinonasal problems).
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2.3 Methods:
2.3.1 NHANES Data Source and Participants
The NHANES is conducted each year by the National Center for Health Statistics
(NCHS) of the Centers for Disease Control and Prevention (CDC). The survey utilizes cluster,
multistage sampling to randomly select households from across the United States. The sample is
nationally representative of civilian, non-institutionalized residents, selected for assessment of
health and nutrition via interview questionnaires, laboratory tests and physical examinations. The
data collected give insight to emerging health issues, risk factors for diseases, and changes in
health problems over time45.
For this study, the continuous NHANES 2011-2012 and 2013-2014 waves were merged
and adults, aged 40 years and older (n=7418) who answered questions on olfactory-related
problems, cigarette smoking, and other potential risk factors, were included in the analysis. The
NCHS Research Ethics Review Board approved all procedures. All participants provided
written, informed consent.

2.3.2 Measures
Chemosensory (CSQ) Questionnaire
The NHANES CSQ questions were formulated to capture perceived taste and olfactory
function. The olfactory-related questions included self-reported ability, symptoms and medical
treatment for dysfunction, and presence of any related risk factors for dysfunction. Affirmative
responses to three questions were used to define self-reported olfactory alteration: perceived
olfactory problems within the past 12 months [yes], phantom odor sensations [yes], and
perceived changes in function since age 25 [worse now]. This index of self-reported olfactory
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alteration has proved reliable46 with 54.4% sensitivity and 78.1% specificity for identifying
anosmia/severe hyposmia1. The dichotomous measure [‘yes’ or ‘no’] for self-reported olfactory
alteration was the outcome variable in data analyses in the present study.

Cigarette Smoking
The smoking portion of the NHANES home interview included questions about daily
cigarette use, history of use, and related details including length of time being a smoker and time
to first cigarette upon waking in the morning47. Serum cotinine was measured as part of the
laboratory procedure in the NHANES mobile examination center. The interview responses and
cotinine levels were used to formulate five classes of smoking status (Table One).
Smokers were classified based on an affirmative response to ever smoking 100 cigarettes
in their lifetime; never-smokers answered “no.” Current smokers answered “yes” to the question
“do you now smoke cigarettes” whereas former smokers answered “no”. Former smokers also
reported the length of time since quitting cigarettes, which was converted into a continuous
measure (years, portion of years).
Packs smoked per year (packs/day X years smoked) defined smokers as light (<10 pack
years, n=1,343) or chronic (≥ 10 pack years, n=1,922) smokers. Chronic smokers were classified
further as current (n=915) or former (n=1,007). Years smoked was calculated for current
(interview age – age reported started smoking) and former [interview age – (age reported started
smoking – reported number of years since quitting)] smokers.
Adding a proxy for nicotine dependence, smoking status was further defined by
incorporating time to first cigarette of the day (TTFC). Current chronic high dependent smokers
were defined as ≥10 PY and time to first cigarette (TTFC) within thirty minutes of waking
(n=582). Light smokers were either <10 PY or did not smoke within thirty minutes (n=697). PY
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also was combined with the available cotinine measure from the NHANES 2011-2012 subset.
Typical levels among non-smokers are <1 ng/mL and those with heavier exposure (e.g.,
secondhand smoke) are 1-10 ng/mL44. In the current study we used a level of ≥10 ng/mL
cotinine to define a smoker48 and to distinguish false self-reports of non-smoking. Thus, chronic
active smokers were defined as ≥10 PY smokers with cotinine levels ≥10ng/mL (n=418) and
current light smokers were <10PY or had <10 ng/mL cotinine (n=422). Never/former smokers
were defined as having serum cotinine <10 ng/mL. Because cotinine metabolism varies between
race/ethnicity groups49, multivariate analyses were also verified using race/ethnicity-specific
cotinine exposure levels 50.
Smoking status also was defined with TTFC and available cotinine levels to compare to
never/former smokers who had cotinine <10 ng/mL. High dependent active smokers reported
TTFC within thirty minutes of waking and had cotinine levels ≥10ng/mL (n=297); light smokers
did not smoke within thirty minutes (n=450) or had <10 ng/mL cotinine (n=450).

Alcohol Consumption
The alcohol use questionnaire was asked in the NHANES examination and probed both
current and lifetime alcohol use trends. A heavy drinker was defined as reporting current or
history of drinking ≥4/5 drinks on most/every day [yes/no]. This variable was examined
independently as a risk factor for olfactory alteration as well as combined with high dependent
smoking, defined as <30 minute TTFC. Adults were classified as either never/former smoker and
heavy drinker (n=628), high dependent smoker and non-heavy drinker (n=391), or high
dependent smoker-heavy drinker (n=214) to compare with neither smokers nor heavy drinkers
(n=4,642).
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Table One: NHANES smoking status class definitions and comparison groups
Smoking status
measure
Chronic Smoker
(≥10 PY Smokers)

Current Chronic High
Dependent Smoker
(≥10 PY, <30 minutes
TTFC smokers)
Chronic Active
Smokers
(≥10 PY, ≥ 10 cotinine
smokers*)
High Dependent
Active Smokers
(<30 min TTFC, ≥ 10
cotinine smokers*)

High Dependent
Smoker-Drinker

Measure definition
Current or former chronic
smokers based on ≥10 PY (packs
smoked per day * years smoked);
Former/current light smokers <10
PY
Current chronic high dependent
smoker based on ≥10 PY who
report smoking within 30 minutes
of waking (TTFC); Current light
smoker based on <10 PY or >30
minute TTFC
Chronic active smokers based on
≥10 PY smokers who also have
cotinine levels ≥10 ng/mL;
Current light smokers based on
<10 PY or cotinine <10 ng/mL
High dependent active smokers
based on reporting smoking
within 30 minutes of waking
(TTFC) and cotinine levels ≥10
ng/mL; Current light smokers
based on >30 minute TTFC or
cotinine <10 ng/mL
Dependent smokers (<30 minutes
TTFC) and who report having
≥4/5 alcoholic drinks on
most/every day

Adults (n=) in smoker group
versus comparison group
Chronic smokers (915 current and
1,007 former) or light smokers
(1,343 ) versus never smokers
(3,942)
Current chronic dependent
smokers (582) or current light
smokers (697) versus
never/former smokers (6,058)

Chronic active smokers (418) or
current light smokers (422) versus
never/former smokers (2,468 )

High dependent active smokers
(297) or Current light smokers
(450) versus never/former
smokers (2,468)

High dependent smokers-drinkers
(214) or never/former smokers
and drinkers (628) or smokers and
non-drinkers (391) versus
never/former smokers and nondrinkers (4,642)

(<30 min TTFC
smoker and heavy
drinker)
*Mean cotinine levels by smoker classification (ng/ml)
Chronic Active Smokers: Never/former 0.13±0.73, Light 148.52±125.82, Chronic Active 265.89±138.05
High Dependent Active Smokers: Never/former 0.13±0.73, Light 193.24±133.68, Dependent Active 275.15±129.66

Olfactory-related Pathologies and Socio-demographic Risk Factors
A number of potential risk factors of olfactory alterations were assessed and examined as
covariates, including socio-demographic variables and olfactory-related pathologies. Education
status was dichotomized to below a high school education or high school education and above.
Race was classified as Mexican American, Other Hispanic, Non-Hispanic white, Non-Hispanic
black, Non-Hispanic Asian, or Other Non-Hispanic/Multi-Race. Income to poverty ratio (family
income divided by federal poverty threshold) also was dichotomized as below (≤ 1) or above
(>1) the poverty line. Marital status was defined as married or not (widowed, divorced,
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separated, or never married). Self-rated health status was dichotomized to poor/fair health or
excellent/very good/good health. A sinonasal problem was defined as report of persistent cold/flu
or frequent nasal congestion in the past twelve months. Other examined risk factors included
xerostomia (persistent dry mouth) during the past twelve months, history of serious head or face
injury, history of tonsillectomy, and history of frequent ear infections (3 or more).

2.3.3 Data Analysis
The NHANES 2011-2014 data set is publicly available for secondary analysis. Because
of the complex sampling design, sample weights were combined between waves and used to
account for over-sampling, survey non-response, and post-stratification. Statistical analyses were
completed using SAS version 9.4 (Cary, NC). All tests were two-tailed and p-values <0.05 were
considered statistically significant.
Univariate associations between self-reported olfactory alterations and potential risk
factors were assessed with chi square tests for categorical variables and two-tailed t-tests for the
age continuous variables. Only chronic/dependent/active smokers, the population of interest,
were compared to never/former smokers in univariate analysis. Post-hoc analysis was completed
for chi-square tests when necessary using adjusted standardized residuals51. Potential risk factors
for self-reported olfactory alteration, including all levels of smoking status, were examined in the
unadjusted and adjusted logistic regression models. Odds ratios were considered significant if the
confidence interval did not include the value one, and risk factors significant in the unadjusted
model were included in the multivariable (adjusted) models. Separate multivariable models were
tested for each smoking status class (Table One). Former smokers were grouped with never
smokers for the analyses, except for the >10 PY (chronic) measurement, as the former group did
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not have significantly greater risk of olfactory alteration compared to never smokers (results not
shown). For the smoking status classes including cotinine, only the NHANES 2011-2012 wave
was available. Due to unequal sample sizes of non-smokers versus chronic active/high dependent
active smokers, logistic regression tests were verified using age and sex matched nonsmokers to
smokers. Matching was completed using propensity scores via the MatchIt package in R
(www.r-project.org).
Mediation models were completed in SPSS using the PROCESS macro. Two models
were examined based on the smoking variables that explained the greatest odds of self-reported
olfactory alteration in multivariable analysis (current chronic high dependent smokers, high
dependent smoker-drinkers). Several other models and directionality of variables were tested
with the displayed models best capturing the data and relationships. The mediator variable was
an olfactory risk score comprised of the significant risk factors for olfactory alteration in the
multivariable analysis, scored from zero to five based on “yes” responses to frequent nasal
congestion, persistent cold/flu, xerostomia, tonsillectomy, or history of a serious head/face
injury. The first model tested whether the olfactory risk score (m) mediated the association
between current chronic high dependent smoking (x) and olfactory alteration (y). The second
model tested whether the olfactory risk score (m) mediated the association between high
dependent smoker-drinkers (x) and olfactory alteration (y). In the mediation models, the a paths
represent the relationship between x and m, and the b paths represent the relationship m and y.
The product of path a and b represents the indirect effect of chronic dependent smoking or
dependent smoking-drinking on olfactory alteration; the c’ path represents the direct effect on
olfactory alteration. Path c, or the total effect, equals the direct plus the indirect effects.
Equations between all variables were tested prior to running mediation modeling to test for
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expected bivariate relationships between x and y, between x and m, and between m and y,
controlling for x. Beta estimates, standard errors, and 95% confidence intervals were used
through bootstrapping procedure using 5,000 resampling to estimate the mediation relationships.
Relationships were considered significant if the confidence intervals did not include the value
zero. The ratio of the indirect effect to the total effect was used to quantify the proportion
mediated. Cases containing missing data were excluded in the analysis and covariates included in
both models were age, sex, race and income-to-poverty ratio.

2.4 Results
Of the sample, 52.3% were never smokers, and 47.4% were former/current smokers.
Table Two provides demographic characteristics of the total sample and by smoking status class.
The mean age of the total sample was 57.8 ± 12.2 years and 47.2% were males. Most adults
reported living above the poverty line and completing high school or above. Smokers, defined by
all five classes, were more frequently male, non-Hispanic White, had lower education level,
lived below the poverty line, and were heavy drinkers.
Of the total sample, 22.3% (n=1609) reported an olfactory alteration. Of those with an
alteration, 32.4% reported loss since age 25 and 26.2% reported both a problem in the past year
and loss since age 25. Among those who reported olfactory alterations, 6.5% reported all three
olfactory-related problems (problems in past year, loss with aging, phantosmia) whereas 20.4%
reported phantom sensations only (without reporting loss with age or smell problems). These
results are comparable to prevalence estimates in the NHANES 2011-20122.
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Table Two: Demographic characteristics of participants in the NHANES 2011-2014 sample
and stratified by smoking status class

Number of
Participants
Gender (%)

7418

Current
and
Former
Chronic
Smokers
1922

Male

47.2

56.6

53.7

58.4

54.5

70.6

Female

52.8

43.4

46.4

41.6

45.5

29.4

57.8 ± 12.2

59.4 ± 11.6

59.8 ± 9.6

54.5 ± 10.5

54.0 ± 10.2

53.2 ± 8.8

Mexican American

6.2

3.1

1.1

1.9

2.4

1.8

Other Hispanic

4.9

3.0

2.7

2.5

2.2

1.9

Non-Hispanic white

71.2

79.9

80.5

79.1

76.5

81.7

Non-Hispanic black

10.7

9.0

9.5

9.6

11.3

10.3

Non-Hispanic Asian

4.8

2.0

1.1

1.0

1.1

<1

Other/Multi-Race

2.2

3.0

5.1

5.8

6.5

4.0

< High school

17.1

21.2

27.5

24.6

26.6

32.7

≥High school

82.9

78.8

72.5

75.4

73.4

67.3

Income to Poverty
Ratio (% ≤1)
Marital Status

12.9

15.6

25.5

17.9

23.1

30.8

Married (%)

63.2

56.6

49.9

51.4

46.9

48.3

15.5

30.5

37.4

33.6

32.7

100

Entire
NHANES
sample

Age (years)

Current
Chronic
High
Dependent
Smokers
582

Chronic
Active
Smokers

High
Dependent
Active
Smokers

High
Dependent
SmokerDrinkers

418

297

214

Race (%)

Education (%)

Heavy Drinkers (%)

2.4.1 Risk factors associated with olfactory alteration examined by univariate analysis
Table Three reports distribution of olfactory alteration by separate potential risk factors,
including the five smoking status classes defined above. There was no significant difference in
prevalence of olfactory alteration between males and females, however adults 80 years and older
most frequently reported olfactory alteration. Post-hoc testing showed that a significantly higher
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proportion of Non-Hispanic White and Other Non-Hispanic/Multi-Race reported olfactory
alteration while fewer Non-Hispanic Black and Asians reported alteration. Adults who were not
married, lived below the poverty line, had self rated fair/poor health, or were heavy drinkers had
significantly greater reported frequency of olfactory alteration. Additionally, greater frequency of
olfactory alteration was reported by those with history of serious head/face injury, tonsillectomy,
ear infections, persistent cold/flu, dry mouth, and frequent nasal congestion. These significant
risk factors are consistent with the NHANES 2011-2012 analysis2. Among the five classes of
smokers, a greater frequency of the smokers reported an olfactory alteration compared to
never/former smokers. Current chronic high dependent smokers reported olfactory alterations
most frequently at 32.8%.
The unadjusted odds ratios and 95% CI for these risk factors also were examined prior to
multivariable analysis to determine significant factors to be included in final adjusted models
(see Supplemental Materials). Significant risk factors included age, not being married, income
to poverty ratio ≤1, sinonasal problems, xerostomia, head/face injury, tonsillectomy, multiple ear
infections, self-rated fair/poor health, and smoking (not light smoking) defined by all five classes
in Table One.
Table Three: Distribution of self-reported olfactory alteration by each potential risk factor
Reported
Total
% of Self-reported Olfactory
Olfactory
Sample
Alteration
Alteration
Test
N
N
% Yes
% No
Statistic and
P-value
57.8
57.6 ±
58.6 ±12.4
T=2.13, 0.04
Age, years (mean)
±12.2
12.2
x2=16.10,
Age strata
0.03
40-49 years
1,934
378
20.4
79.6
50-59 years
1,852
402
22.8
77.2
60-69 years
1,848
406
22.3
77.7
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70-79 years
80+ years

1,069
715

216
207

22.1
28.3

77.9
71.7
x2= 0.28,
0.87

Sex
Male
Female

3,556
3,862

747
862

22.4
22.2

77.6
77.8
x2=30.52,
0.001

Race/Ethnicity
Mexican-American
Other Hispanic
Non-Hispanic black
Non-Hispanic white
Non-Hispanic Asian
Other/Multi-Race

803
737
1,777
3,047
894
160

172
162
351
761
118
45

21.3
21.9
19.4
23.2
13.1
30.9

78.7
78.1
80.6
76.8
86.9
69.1
x2=10.32,
0.001

Marital Status
Married
Not Married

4,301
3,108

844
762

21.0
24.3

79.0
75.7
x2=2.58,
0.23

Education
< High school
≥High school

1,925
5,484

433
1,176

24.0
22.0

76.0
78.0
x2=16.71,
0.0001

Income-to-poverty ratio
IPR ≤1 (poverty)
IPR > 1

1,426
5,322

377
1,112

27.9
21.7

72.1
78.3
x2=50.20,
0.0001

Self-rated health
Fair or poor
Excellent, v. good, good

1,793
4,704

514
924

30.0
20.8

70.0
79.2
x2=55.91,
<0.0001

Heavy Alcohol Use
Yes
No
Current & Former
Smokers
Chronic Smokers
Never-smokers
Current Smokers

986
5,464

281
1,142

31.8
21.0

68.2
79.0

1,922
3,942

544
725

29.3
19.1

70.7
80.9

x2=77.82,
<0.001

Chronic High Dependent Smokers

582
6,058
418
2,468

181
1,243
134
542

32.8
21.2
30.6
22.0

67.2
78.8
69.4
78.0

x2=44.96,
<0.001
x2=15.98,
0.048

Never/former smokers
Chronic Active Smokers
Never/former smoker
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297
2,468
214
4,642

97
542
70
936

31.3
22.0
37.6
20.5

68.7
78.0
62.4
79.5

Serious head/face injury

1,573

465

28.2

71.8

Ear infections, 3+ times

1,397

423

27.8

72.2

Tonsils removed

1,853

476

26.0

74.0

Cold/flu for >1 month

478

182

38.8

61.2

Persistent dry mouth

1,115

424

37.5

62.5

Frequent nasal congestion

2,055

671

32.2

67.8

High Dependent Active Smokers

Never/former smoker
High Dependent Smoker-drinkers
Never/former smoker, non-drinker

x2=13.99,
0.04
2
x =37.37,
<0.0001

Olfactory-related risk
factors
“Yes,” have ever had…
x2=53.26,
0.0001
x2=44.67,
0.0001
x2=28.23,
0.001

“Yes,” in last 12 months
x2=76.22,
0.0001
x2=149.82,
0.0001
x2=168.09,
0.0001

2.4.2 Examination of smoking status as a risk factor for olfactory alteration by multivariable
analysis
The adjusted models were tested with each class of smoker. Significant independent risk
factors of olfactory alteration in all models include sinonasal problems and xerostomia. The
significance of other risk factors (history of a serious head/face injury, tonsillectomy, poor selfrated health, heavy alcohol use, poverty) varied between the adjusted models. In former smokers,
a greater number of years since quitting smoking was not associated with lower odds of an
olfactory alteration when controlling for age and sex (OR: 1.00; CI: 0.99-1.01).
In fully adjusted models, smoking status measured by PY alone and TTFC with PY
remained significant risk factors for olfactory alteration (Figure One: Model A-D). Model A
found that chronic smokers (former and current) versus never-smokers were at significantly
greater odds of olfactory alteration (1.36, CI: 1.06-1.74). However, when former and current
chronic smokers were examined separately (Model B) in the adjusted model, only former chronic
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smokers remained at significantly greater odds (1.42, CI: 1.09-1.84) and current chronic smokers
did not (1.29, CI: 0.93-1.80). TTFC <30 minutes was not a significant risk factor alone (1.30, CI:
0.94-1.79), but current chronic high dependent smokers were at significantly greater odds of an
olfactory alteration versus never/former smokers (1.41, CI: 1.01-1.99) (Model C). No significant
difference in odds of an alteration was seen between light smokers and never/former smokers in
any model.
The cotinine biomarker as a measure of current smoking status did not add predictive
ability. There was non-significant greater odds that chronic active smokers [1.22, CI: 0.72-2.05]
or high dependent active smokers [1.22, CI: 0.77-1.93] had olfactory alteration versus
never/former smokers. Chronic active smokers and high dependent active smokers compared to
age and sex matched never/former smokers were also not at increased odds of an olfactory
alteration. Furthermore, cotinine alone as a continuous measure of smoking, or by race specific
cut-off points, was not a significant risk factor for olfactory alteration.
High dependent smoker-drinkers were at the greatest risk for olfactory alteration than any
of the smoking measures alone (1.96, CI: 1.20-3.19) (Model D). Being a dependent smoker and
non-heavy drinker or non-smoker and heavy drinker were not significant risk factors. All
smoking variables were tested with heavy alcohol use; TTFC with heavy alcohol produced the
highest odds ratios with olfactory alteration.
Figure One: Forest plots of adjusted odds ratios and 95% confidence intervals of risk
factors associated with self-reported olfactory alteration in U.S adults in models examining
A) Current and former chronic smokers B) Chronic smokers stratified by current and
former C) Current chronic high dependent smokers D) High dependent smokers-drinkers
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2.4.3 Examination of the indirect relationship with olfactory alteration through mediation
modeling
Table Four and Figure Two display the two mediation models, beta estimates with 95%
confidence intervals of pathways, indirect, and direct effects when controlling for age, gender,
race/ethnicity, and poverty. The first model displays the indirect relationship between current
chronic high dependent smokers with olfactory alteration through olfactory risk score. All of the
beta estimates (path a and b) were positive, suggesting that with moving from never/former
smokers to chronic high dependent smokers, there was greater number of olfactory risk factors,
which resulted in greater risk of olfactory alteration. Both the direct and indirect effects were
significant (0.3786, CI .1707-.5865; 0.1043, CI: .0611-.1538) indicating partial mediation. Of the
relationship between smoking and olfactory alteration, 21.6% was mediated via olfactory risk
factor score.
The second model showed similar, but more significant results. Moving from a
never/former smoker and non-drinker to a high dependent smoker-drinker was associated with
greater olfactory risk factor score, which was associated with greater risk of olfactory alteration.
The direct (0.3651, CI: .0373-.6929) and indirect (0.1884, CI: .1155-.2767) effects were both
significant. Of the relationship between smoking-drinking and olfactory alterations, 34.0% was
mediated via olfactory risk factor score.
Table Four: Beta estimates, standard error, and 95% confidence intervals of the mediation
relationship of smoking/smoking and heavy drinking relationship with self-reported
olfactory alteration
Relationships
Chronic high dependent
smokingolfactory risk score (a)
Olfactory risk scoreolfactory
alteration (b)
Chronic high dependent
smoking olfactory alteration (c’)
Indirect Effect
†Covariates

Estimate

Standard Error

CI

0.234

0.045

0.147-0.322

0.445

0.031

0.384-0.507

0.379

0.106

0.171-0.587

0.104

0.024

0.061-0.154

controlled for include age, gender, race/ethnicity, and poverty
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Relationships

Estimate

Standard Error

CI

High dependent smokerdrinkerolfactory risk score (a)
Olfactory risk scoreolfactory
alteration (b)
High dependent smoker-drinker
olfactory alteration (c’)
Indirect Effect

0.426

0.069

0.290-0.562

0.442

0.038

0.367-0.517

0.365

0.167

0.037-0.693

0.188

0.040

0.116-0.277

†Covariates

controlled for include age, gender, race/ethnicity, and poverty

Figure Two: Models of the association between (A) chronic high dependent smoking or (B)
high dependent smoking-drinking and self-reported olfactory alterations mediated by
olfactory risk score in data from the National Health and Nutrition Examination Survey
2012-2014.
A.

B.

2.5 Discussion
With the addition of the Healthy People 2020 chemosensory goals and the data from the
new chemosensory protocol in the NHANES 2011-2104, alterations in the sense of smell are
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gaining more attention as a prevalent health problem. Analysis of the 2011-2012 and 2013-2014
waves revealed an estimated prevalence of altered olfaction at 22.3% across U.S adults ages ≥40
years, including problems in the past year, loss since age 25, and/or phantom olfactory
sensations. This prevalence is nearly equivalent to the initial estimates from 2011-2012
NHANES (23%) 2. Compared with never/former smokers, a significantly greater frequency of
smokers reported an olfactory alteration, ranging from 29.3-32.9% depending on how smoking
was characterized. High dependent smokers who also were heavy alcohol drinkers had the
highest frequency of self-reported olfactory alteration at 37.6%. The association between chronic
high dependent smoking or dependent smoking-drinking and olfactory alteration was partially
mediated (21.6-34%) by an olfactory risk score, comprised of pathologies associated with
olfactory dysfunction (frequent nasal congestion, persistent cold/flu, presence of xerostomia,
tonsillectomy, or history of a serious head/face injury).
The estimated prevalence of self-reported olfactory alteration is almost double that of
measured olfactory dysfunction at 12.4%1 from the initial analysis of the 2012 NHANES. The
self-report measure captures perceived changes in function with aging as well as phantosmia,
neither of which are captured with a single measurement of olfactory function52. In contrast, two
previous population-based studies reported greater measured olfactory dysfunction at 19-24.5%
among adults than that with a single question about self-reported olfactory problems at 9.515%4,25. Based on previous analysis, all three questions used in the olfactory alteration index
contributed to the prevalence estimated and showed a sensitivity of 54.4% (correctly identifying
dysfunction) and a specificity of 78.1% (correctly identifying normal function) when compared
with measured anosmia/severe hyposmia1. The NHANES olfactory alteration index also
associated significantly with previously identified risk factors for olfactory dysfunction2,
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including sinonasal problems8,24, xerostomia53, history of a serious head/face injury9,
tonsillectomy54, and poverty55. This self-report measure may be more beneficial than measured
olfaction for the current study, as we were examining chronic cigarette use, and not just current
use. The perceived changes in olfactory function over time are therefore important to capture,
and measured testing does not have the ability to pick this up, or the ability to detect phantom
sensation, both which contribute to olfactory issues. As previously2, we did not observe that
males self-reported higher rates of altered olfaction, in contrast to gender differences observed
with measured function in NHANES 2012 (males 3 times more likely to have severe
hyposmia/anosmia than females1), or other population-based studies 5,25.
Interestingly, in the recent analysis of the NHANES 2011-2012 olfactory data, cigarette
smoking appeared as a protective factor for measured olfactory function1 and had a nonsignificant effect on self-reported olfactory function2. However, in the current analysis, cigarette
smoking was a risk factor for self-reported olfactory alteration, when characterized by chronicity
(≥10 PY), dependency (time to first cigarette <30 minutes) and when combined with heavy
drinking. The chronicity of smoking measured in pack years (≥10 PY) significantly increased
odds of self-reported olfactory alteration in former and current smokers when examined together,
but not in current chronic smokers alone. In current smokers, those who were both chronic and
dependent smokers were at an increased risk for olfactory alteration versus never/former
smokers. Pack years or TTFC alone as a measure of current smoking did not associate with an
increased risk of olfactory alterations, and these measurements had to be looked at together to
see increased odds.
To our knowledge, only four other studies have used pack years as a measure of smoking
in examining the association with olfactory function. One study found no association with
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olfactory dysfunction when examining pack years in former and current smokers, or heavy use
(>20 cigarettes/day) among current smokers25. However the other three studies found a doserelated response with pack years in current smokers, who had increased olfactory thresholds56, as
well as a worse odor discrimination and odor identification27,57. These previous studies, however,
did not control for as many other known risk factors in multivariable analysis as done in the
present study (e.g., sinonasal issues, head trauma, xerostomia). None of the existing studies have
used time to first cigarette as a measure of smoking to examine olfactory alterations. This
measure has been used to examine numerous other outcomes, such as quitting success58,
hypertension59 and COPD or pulmonary impairment43,60. TTFC corresponds well with
biomarkers of smoking, such as nicotine, cotinine, and hydroxycotinine concentrations61 and is a
fast and inexpensive measure of nicotine dependence. The results from the present study suggest
that it is important to characterize smoking thoroughly, capturing chronicity (PY) and
dependency (TTFC), to accurately assess risk for olfactory alteration.
We did not find an association with years since quitting smoking and improvement in
olfaction in former smokers, as observed by Frey et al 27. One potential reason for the lack of
findings in the present study could be the older age of our sample. Frey et al examined
participants aged 17 to 69 (mean age 42.9 years), compared to the present study’s mean age of
57.8 years. Advanced age is known to be associated with decreased smell function13. An increase
in years since quitting is also accompanied by an increase in age, which may counter the positive
effects of quitting on olfactory function, resulting in an insignificant finding. In addition, the
Frey et al study did not control for other demographic and pathology-related risks for olfactory
dysfunction.
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Although TTFC measure has been shown to associate with cotinine levels, using serum
cotinine as a measure of smoking status did not strengthen its association with self-reported
olfactory alteration in this study. Cotinine was verified by race-specific cut off points, however
there is still not a universal cut-off point verified to distinguish smokers and non-smokers, or
heaviness of smoking. A systematic review examining 67 studies that measured self-reported
smoking status and serum cotinine levels found that cut-off points used ranged from 8 ng/mL to
100 ng/mL62. Along with race, gene expression and medications competing with binding
substrates63, as well as gender64 may all play a role in cotinine metabolism, and therefore cause
variations person to person. Additionally, although cotinine has a longer half-life than nicotine, it
remains in the system for only 15-20 hours65, which still may not capture the chronic, dependent
smokers who seem to be most at risk for olfactory alteration. The cotinine measure is invasive
and expensive, and, according to this analysis, appears less predictive of risk for olfactory
alteration than the self-reported cigarette smoking behaviors.
The combination of smoking and heavy drinking showed a synergistic effect. Being a
dependent smoker and not a heavy drinker, or vice versa, was not a significant risk factor for
altered olfaction in the adjusted logistic regression model, but the joint effect of the two
associated with the highest risk. Although smokers tend to be heavy drinkers37, their joint effect
has not been examined previously as a risk factor for olfactory alteration. Instead, studies use
smoking as a covariate when examining the association with alcohol use40,41. The present
findings that the association between smoking and olfactory alteration depends on the
smoking/heavy drinking relationship, chronicity of smoking, and/or dependency may partly
explain the inconsistent reports in the literature.
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The findings of the present study suggest that chronic dependent smoking alone, or in
combination with heavy drinking, may increase risk of olfactory alteration through pathologies
associated with olfactory dysfunction. That is, 22 and 34% of the association between smoking
alone or with heavy drinking was explained by an olfactory risk score comprised of five
pathologies (frequent nasal congestion, persistent cold/flu, presence of xerostomia,
tonsillectomy, or history of a serious head/face injury). The direct effect of chronic dependent
smoking as well as smoking and heavy drinking on olfactory alterations was also significant,
indicating these behaviors also likely have a direct effect on olfactory alteration. Although the
relationship between smoking, olfactory alterations, and these other olfactory pathologies have
been examined independently, no study to our knowledge has examined this complex
relationship simultaneously. Mediation modeling allows for testing of all variables and their
relationships together, displaying the complex associations between all. This provides additional
information that logistic regressions cannot, as regressions look at relationships separately, not as
a whole66.
Although this study utilized a nationally-representative sample of U.S adults, there are
still limitations to acknowledge, including the cross-sectional design. The present study
examined a variety of risk factors for olfactory alteration, however a few other risk factors were
not considered such as physical activity levels and BMI. Additionally, measures of smoking that
included cotinine levels were limited in sample size as they were only available in the NHANES
2011-2012 wave and only self-reported olfactory alteration was examined. However, smoking
status was measured using multiple indicators of heavy use and dependence through selfreported and measured data. Future research should utilize the shown appropriate measures of
smoking to accurately capture who is at risk for olfactory alteration, including the combination
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of pack years and time to first cigarette in current smokers and pack years in former smokers. In
addition, the relationship between smoking and olfactory function can be examined utilizing the
new measured protocol in NHANES 2013-20141. Finally, other complex mediation relationships
and combined lifestyle factors (e.g., heavy drinking) should be examined to fully understand the
relationship of cigarette smoking on olfactory function.

2.6 Conclusion
In conclusion, this nationally-representative study found significant evidence that chronic
dependent cigarette smoking alone or with heavy alcohol consumption was associated with
increased odds of olfactory alteration, a composite index capturing self-reported problems during
the past year, losses noticed with age, and phantom olfactory sensation. Some of the risk of
olfactory alteration in smokers or smokers/heavy drinking was direct and some was explained by
an increased frequency of pathologies associated with olfactory dysfunction (frequent nasal
congestion, persistent cold/flu, presence of xerostomia, tonsillectomy, or history of a serious
head/face injury). The smoking effects on risk of altered olfaction were uncovered by
characterizing smoking by chronicity as well as level of dependence.
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CHAPTER THREE
Heightened olfactory dysfunction and oral irritation among chronic smokers and
heightened propylthiouracil (PROP) bitterness among menthol smokers

3.1 Abstract
Chronic cigarette smoking can influence chemosensory function, which in turn affects the
palatability of tobacco products and cessation efforts. We examined chemosensory function of
chronic smokers in comparison to a national sample for olfaction (National Health and Nutrition
Examination Survey, NHANES) and to a sample of non-smokers for taste. Chemosensation also
was evaluated as a function of menthol versus non-menthol cigarette use. We expected that
chronic smokers would display altered chemosensory function that would vary by menthol use.
Methods: Chronic smokers (N=78; 49 menthol smokers) self-reported their chemosensory
function (per NHANES protocol) and participated in measures of smell (16-item olfactometer
identification task) and taste (quinine and NaCl intensities, NHANES protocol) function,
including a taste genetic probe (bitterness of propylthiouracil, PROP). Self-reported and
measured olfactory function was compared with 2011-2012 NHANES data, and taste function
was compared with age- and sex-matched non-smokers (n=311). Results: Olfactory alterations
were reported by 25% of smokers, similar to NHANES prevalence. However, measured
dysfunction (22% mild, 35% moderate, 3.8% severe microsmia and 1% anosmia) exceeded that
reported in NHANES, but did not differ by menthol cigarette use. Taste alteration, including
altered flavor, was reported by 15% of smokers. In comparison with non-smokers, smokers
reported elevated intensities from NaCl at oral-irritant concentrations. Consistent with previous
TAS2R38 taste receptor gene findings, menthol smokers reported greater bitterness from PROP
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than non-menthol smokers. These findings have implications for regulation of flavorings in
tobacco. As with menthol cigarette preference among smokers with genetic propensity for
elevated bitter perception, other flavors may also help drive smoking in chronic smokers with
altered chemosensory function.

3.2 Introduction
Although smoking prevalence has been declining over the past years, in 2014 over 40
million adults (16.8%) in the United States were current smokers1. Of all cigarettes sold in 2012,
31% were a mentholated brand2 and used more frequently by younger individuals and minority
groups, specifically African Americans3. Makers of tobacco-based products commonly use
flavor additives to mask bitterness, irritation and other unpleasant sensations from tobacco and to
produce a smooth, mellow tobacco flavor. In particular, menthol has been used to produce a
smoother, cooler smoke. Genetic variation in sensitivity to flavors and taste may influence
smoking choices and behaviors. Thus, we sought in the present paper to investigate olfactory and
taste function among adults who are current chronic smokers, and compare chemosensory
function between menthol vs. non-menthol smokers.
In population-based samples, the rates of olfactory dysfunction range from 3.8%4,5 in the
Beaver Dam Offspring Study, to 12.4% for the National Health and Nutrition Examination
Survey (NHANES)6, and l9.1% for the Skövde population-based study7. These rates vary with
demographic factors, with increased rates in older adults6,8,9, males9-14, certain ethnic/racial
minorities6,9 and those with lower income/educational attainment5,6. Common causes of
olfactory alterations include frequent nasal infections, allergies15, injury to the head or face16
[16], and viral infections/tonsillectomy6. Studies show that individuals are able to self-report

- 44 -

having a normal sense of smell (i.e., specificity) but are poor at self-detecting olfactory
dysfunction (i.e., sensitivity)17,18. However, through asking a series of questions about recent
smell function, loss of sense of smell with aging, and phantom sensations (i.e., phantosmia), we
have been able to achieve reasonable sensitivity in tests of self-identified olfactory dysfunction19.
Research on the association between smoking and risk of olfactory dysfunction has been
inconsistent. Several studies report no association between olfactory function and smoking when
examining both measured and self-reported function in current compared to former or neversmokers7,19-21. Other studies show an elevated risk of olfactory dysfunction among current
smokers8 and/or heavy smokers8,22. Recent analysis of the NHANES 2012 data, on the other
hand, suggested decreased risk of olfactory dysfunction among current and past smokers, yet
found an elevated risk of olfactory dysfunction among heavy drinkers6.
Compared with olfactory dysfunction, taste dysfunction is less common23, due to the
redundancy of the three taste-related nerves that carry the sensory information from the
periphery to the central nervous system. More common is regional taste dysfunction from an
area of taste nerve innervations, which in turn alters whole mouth taste perception, touch/tactile
and pain sensations24. More severe taste-related exposure could depress whole mouth taste
function. Major causes of taste dysfunction include xerostomia (persistent dry mouth), facial
injuries, upper respiratory and middle ear infections, surgeries to the ear, nose or throat, and
aging24. Since individuals are usually unable to perceptually distinguish taste and retronasal
olfactory sensations during ingestion, NHANES protocol queried on the ability to taste salt,
sweet, sour and bitter, along with questions on changes in food flavor, and persistent tastes in the
mouth (i.e., dysgeusia), which was combined into a taste alteration index19. The prevalence of
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reported taste alteration (recent problems, loss in taste or flavor with age, dysgeusia) in adults 40
years and older was 19%19.
There are natural variations in the ability to taste, specifically, the ability to taste
PTC/PROP bitterness relates to polymorphisms in the TAS2R38 receptor gene25,26. Given these
taste variations, the question of interest was to determine if heightened ability to taste might be a
sensory hindrance to smoking (or to smoking unflavored cigarettes), and if chronic smoking
alters taste and oral sensations. Although nicotine stimulates complex taste, olfactory and
somatosensory sensations27, variation in bitter taste has been linked to differences in cigarette
smoking behaviors. Nicotine stimulates bitter taste through TRPM5-dependent and independent
mechanisms28. Fischer29 in the 1960’s reported that smokers are less sensitive to bitter taste. In
recent studies of bitter taste in humans, specifically bitterness of phenylthiocarbamide (PTC) and
propylthiouracil (PROP), nontasters are more likely to be smokers30, show greater cigarette
dependence31, and less nicotine aversion32. Additionally, PTC/PROP nontasters by TAS2R38
genotype show more motivation to smoke based on sensory cues than do tasters33. It should be
noted, however, that the TAS2R38 genotype-smoking effects are not always seen34, and the
effects may be race/ethnicity specific35. Menthol in cigarettes may help smokers block the
negative oral sensations from cigarettes36,37. Females who are PTC/PROP tasters by TAS238
receptor genotype are more likely to smoke menthol cigarettes38.
Smoking itself may impair bitter taste perception or alter oral sensations, and smoking
cessation may lead to improvements in bitter taste ability32. Additionally, taste perception plays
a key role in flavor preference39 and differences among smokers may influence flavor choice
among nicotine products, such as mentholated cigarettes or electronic cigarettes. Long-term
exposure to nicotine in rats decreased fungiform papillae size and changed their anatomical
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characteristics40, which could explain lower density of tongue-tip taste papillae (fungiform
papillae) among chronic smokers41. Most studies report altered oral sensations among smokers,
however the type of alteration varies. Studies have found elevated taste42 and touch43 sensations,
elevated taste44 or taste/touch thresholds45, and greater risk of oral pain46 among smokers. One
study found no smoker effects on taste threshold47.
Due to the complexity of smoking’s potential effects on chemosensory functioning, the
aim of this study was to compare olfactory and taste function in chronic smokers with the
olfactory functioning of a national sample from the National Health and Nutrition Examination
Survey and the taste functioning of age- and sex-matched non-smokers. Additionally, we were
particularly interested in the olfactory and taste function of menthol and non-menthol smokers.
Finally, because this was a baseline examination of an electronic cigarette study, we aimed to
identify if the flavor electronic cigarette smokers identified as their most preferred associated
with their chemosensory functioning, or menthol status. It was hypothesized that chronic
smokers would display altered chemosensory function, which would vary by menthol use and
that electronic cigarette flavor preference would vary by menthol status or PROP taster profile.

3.3 Methods
3.3.1 Study Design and Participants
The analysis sample of 79 adults (42 males) was obtained from the baseline data of a
study on the effects of nicotine and flavorings on use of electronic cigarettes in regular smokers.
Recruited into this study were adults in the greater Hartford, CT area, ages 18 to 55 years, who
responded to newspaper and radio advertisements between May 2015 and March 2016. A
telephone screening protocol determined if the potential participants met the exclusion and
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inclusion criteria for initial eligibility. The criteria for exclusion were: 1) unstable medical or
psychiatric disorders, including uncontrolled hypertension (BP>160/100); 2) pregnancy; 3)
known hypersensitivity to nicotine or to propylene glycol; 4) previous M.I. or stroke; 5) insulin
dependent diabetes; 7) and known COPD or asthma. The criteria for inclusion included 1)
current use of at least 10 cigarettes daily; 2) willing to abstain from cigarette smoking, and to
substitute e-cigarettes, for approximately 6 weeks; 3) not currently planning to stop smoking
(score <-2 on an Intentions to Quit scale48); and 4) able to read and sign a consent form in
English. The study was approved by the institutional review board at the University of
Connecticut Health Center. Participants provided informed and written consent and were paid
$20 for participation in the baseline assessments.

3.3.2 Procedure and Measures
Adults who met the inclusion/exclusion criteria were invited to participate in the baseline
measurements. During the initial screening process, participants completed the Smoking History
Questionnaire [SHQ]49, a self-report questionnaire used to assess smoking history and pattern.
The SHQ includes items pertaining to smoking products, brands used and smoking rate.
Responses to brand used, specifically if a menthol brand is used, classified participants as nonmenthol or menthol smokers. Pack years were calculated based on smokers reported average
cigarettes smoked/day since being a regular smoker, converted to packs a day, and multiplied by
reported years smoking. Smokers were also classified by time to first cigarette (TTFC) upon
waking (within 30 minutes or >30 minutes). TTFC is a marker for nicotine dependence50. During
baseline procedures, participants also sampled five electronic cigarette flavors, by puffing on
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them for one minute each, and rated their most preferred flavor (no flavor, tobacco, menthol,
cherry, and chocolate).
The chemosensory protocol took approximately 20 to 25 minutes during a 2-hour visit to
the UCHC Clinical Research Center. Participants first self-reported their olfactory and taste
functioning using the NHANES protocol19,51, including problems within the past year, losses
since age 25 years, and phantom sensations (dysgeusia, phantosmia/parosmia). Self-reported
smell or taste alteration was an affirmative/negative response to having a problem within the past
year, worse abilities since age 25, or a phantom sensation.
All sensory intensity ratings were made on the general Labeled Magnitude Scale (gLMS),
which generalizes the LMS52 to all sensations53. The gLMS scale ranges from 0=nothing to
100=strongest sensation of any kind, and intermediate labels of 6=barely detectable,
17=moderate, 35=strong, and 53=very strong. Participants were trained on using the generalized
labeled magnitude scale (gLMS) following the procedures outlined in the NHANES but
practicing the ratings with remembered sensations54 instead of LED-generated brightness
sensations used for intensity ratings6. Previous research has shown that the gLMS generates
intensity ratings consistent with magnitude matching53.
Olfactory function was measured using a 16-item odor identification task and intensity
ratings for each odor on the gLMS54. The participants were instructed to identify the correct
odor generated by an olfactometer (Osmic Enterprises, Inc., Cincinnati, OH) from four choices.
Stimuli included food (cherry, strawberry, lemon, onion, coffee, cinnamon, chocolate, grape,
vanilla), warning (gasoline, smoke, menthol) and household (soap, leather, baby powder, rose)
odors. Participants who identified fewer than thirteen odors correctly were classified as having
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an olfactory dysfunction (0-7 anosmia/severe hyposmia, 8-12 hyposmia). Those correctly
identifying thirteen to sixteen odors were classified as normosmia.
Taste functioning was measured with the NHANES protocol6,54. Participants used the
gLMS to report the intensity of concentrated 1mM quinine hydrochloride (QHCl) as well as 1M
and .32 M sodium chloride (NaCl) drawn across the tongue tip and then sampled with the whole
mouth54. As a probe of genetic variation in taste26,55, participants also reported the intensity of 1
and 3.2 mM PROP sampled with the whole mouth. For analysis, participants were classified as
nontasters if they reported the average intensity of PROP less than moderate on the gLMS,
medium tasters between moderate and very strong, and supertasters greater than very strong.
Retronasal function was measured using a jelly bean plug/unplug taste test. Four jelly
bean flavors, cherry, coffee, chocolate, and Tabasco were used. Participants first rated the
sweetness/flavor intensity of the jelly bean with their nose plugged using the gLMS. Then
participants unplugged their nose and again rate the sweetness, flavor intensity, and their liking
or disliking of the flavor. For the Tabasco jelly beans, participants also rated the intensity of the
burn or irritation feeling while unplugged. The difference in flavor intensity rating from plugged
to unplugged were calculated to examine retronasal function.

3.3.3 Data Analysis
Statistical analyses were conducted using SPSS version 22 (Chicago, IL) with
significance criterion of p≤.05. Descriptive analysis was used to compare self-rated and
measured olfactory/taste functioning between smokers and the NHANES 20126,19 overall and by
age decade.
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Smokers were matched to a non-smoker sample (n=311) from our laboratory database
using propensity score matching with the MatchIt56 R package (www.r-project.org). The
propensity score was estimated by logistic regressions matching for age and sex initially and then
for age, sex and PROP tasting to test for differences in quinine and NaCl intensity (which vary
with PROP bitterness53,57) using the method of nearest to match non-smokers to smokers with the
closest propensity score. A 3:1 control to case ratio was used, which is preferred over 1:1
matching for increased statistical power and decreased standard errors58,59. Differences in taste
function between smokers and non-smokers or within menthol and non-menthol were first
assessed with group and sex analysis of covariance, controlling for age effects, and then assessed
for differences in distribution with either chi-square or Kolmogorov-Smirnov test.
Retronasal jelly bean tests and preferred electronic cigarette ratings were examined for
correlations and associations with olfactory and/or taste dysfunction as well as differences by
menthol status or PROP taster classification.

3.4 Results
Table One describes the socio-demographic, lifestyle behaviors, and health conditions of
the study participants by menthol smoker status. Average age of the entire sample was 35 ± 10
years. The average years smoked of the sample was 18.2 ±11 years, with an average of 11.5 ±
9.3 pack years. Eighty-one percent of the sample reported smoking within 30 minutes of waking
in the morning.
Significantly more menthol smokers were single/divorced than non-menthol smokers (x2=
7.36, p<.01), having less than $40,000 household income (x2= 10.9, p<.01) than non-menthol
users, and significantly more were Black (x2=4.24, p=0.04) compared to non-menthol users. In
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comparison with a general population sample of adults in Connecticut from the Behavioral Risk
Factor Surveillance System for Connecticut in 201360, fewer smokers in the current study were
of normal weight (23.1 vs 35.6%, respectively), and more were obese (39.7 vs. 25%,
respectively).

Table One: Demographic and health characteristics of chronic smokers by menthol
smoking status
Characteristics

Non-Menthol
(32)

Menthol
(47)

56.3%
43.8%
35.5 ± 9.6

51.1%
48.9%
34.8 ± 10.5

46.9%
53.1%

76.6%
23.4%

6.3%
93.8%
0%
71.9%

23.9%
71.7%
4.3%
34.0%

6.3%
93.8%
19 ± 9.6
12.9 ± 6.6
28.5
0%
31.3%
37.5%
15.6%
6.3%
9.4%
18.8%
3.1%
12.5%
25.0%
31.3%

6.5%
93.5%
17 ± 12
12 ± 6.5
29.9
2.1%
23.4%
34.0%
21.3%
10.6%
8.5%
14.9%
8.5%
10.6%
29.8%
25.5%

Gender
Male
Female
Age (years) (mean ± SD)
Marital Status
Single
Married
Race
Black
White
MultiRace
Household Income >$40,000
Education Level (%)
< High school
≥ High school
Average Years Smoked (mean± SD)
Average Cigarettes smoked/day (mean ± SD)
Average BMI
Underweight (<18.5)
Normal (18.5-24.9)
Overweight (25-29.9)
Obese Grade I (30-34.9)
Obese Grade II (35-39.9)
Obese Grade III (≥40)
Tonsils Removed
Persistent Cold/flu
Persistent Dry Mouth
Frequent nasal congestion/allergies
Suffered from a serious head injury
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3.4.1 Self-reported olfactory and taste alteration
As shown in Table Two, the percent of chronic smokers reporting alteration in olfaction,
taste or both was very similar to that found in the NHANES 2011-201219. However, there was
less overlapping of the responses in forming the alteration indexes, as fewer chronic smokers
reported phantom smell or taste sensations.
Table Two: Rates of self-reported olfactory and taste alteration compared with the
NHANES 2011-1219 and olfactory dysfunction compared with the measured prevalence in
the NHANES 20126
% of
Prevalence in
†
Self-reported Alteration
NHANES 2011-2012
Smoker Sample (n=79)
(n=>3000)
25.3
23.0
Olfactory Alteration
Smell problem in last year
12.7
10.6
Loss since age 25
14.1
16.7
Phantom odors
1.3
6.0
15.2
18.7
Taste Alteration
Taste problem in last year
7.6
5.3
Loss since age 25 (salt, sweet, sour, or
1.5-5.1
3.6-4.7
bitter)
Loss of food flavor since age 25
6.4
10.0
Dysgeusia
0.0
5.0
Combined Olfactory and Taste Alteration
Measured Olfactory Dysfunction
Total
Anosmia/Severe Hyposmia
Hyposmia
Normosmia
† Sub-scores

11.4
% of
Smoker Sample (n=78)
40.5
1.4
39.2
58.2

10.0
Prevalence in
NHANES 2012
(n=1281)
12.4
3.2
9.2
87.6

will not sum to total alteration index because of overlapping responses.

3.4.2 Measured olfactory function
The rate of olfactory dysfunction among this sample of chronic smokers was 40.5%,
which was higher than the 12.4% overall NHANES prevalence (8-item scratch and sniff odor
identification task)6, which included adults from the 4th to 8th decades of age (Table Two). The
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rate of hyposmia in chronic smokers (39.2%) also exceeded the rates in NHANES among those
in the 4th (2.5%) and 5th (8.1%) decades of age6. The percentage of chronic smokers with
olfactory dysfunction increased with age; 33% in those less than 40 years of age, 40% in those
under 50 and 100% in those 50 to 55. The number of odors correctly identified did not vary
significantly among the female and male smokers. Rates of olfactory dysfunction among
smokers did not vary by menthol status (35.5% non-menthol vs. 44.7% menthol) yet the menthol
smokers tended to have greater variance in the distribution (F-test on variances=1.85, p=0.07).
Rates of olfactory dysfunction among ≥10 pack year smokers (average 19.2 pack years) were
48.6% compared to 35% in <10 pack year smokers (average 4.5 pack years). This was not a
statistically significant difference (p=0.25) and did not vary by menthol status.
Olfactometry indicated that prevalence of olfactory dysfunction among the chronic
smokers was much higher than that suggested by self-report. Comparing the sensitivity and
specificity of self-report against measured olfactory alteration, individuals had much better
specificity (correct identification of normal), at >76.3%, than sensitivity (correct identification of
dysfunction) at <50%. The best sensitivity and specificity was found in individuals who
identified ≤10 smells correctly, indicating that individuals with more severe dysfunction are
better at identifying when they have a problem than individuals with mild dysfunction.
Of the specific odors, onion (100% identified it correctly) and coffee (97.4% identified
correctly) were the odors most frequently identified correctly. Chocolate (51.3% identified
incorrectly) and gasoline (51.3% identified incorrectly) were the odors most frequently identified
incorrectly. Of the overall sample, 24.4% did not correctly identify menthol, with more menthol
smokers not identifying the odor correctly compared to non-menthol smokers (27.7% vs. 19.4%
misidentified respectively); this difference did not reach statistical significance. The intensity of
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the odors ranged from ≤moderate (chocolate, menthol), moderate to strong (strawberry, gasoline,
smoke, lemon, cinnamon, rose, vanilla, cherry, leather, baby powder), to ≥strong (soap, grape,
coffee, onion). In odors repeated in our previous study, compared with age- and sex matched
non-smokers54, these chronic smokers reported significantly lower intensities for smoke, coffee,
menthol and onion but not for chocolate.

3.4.3 Measured taste function
Relative to non-smokers, the smokers tended to have higher PROP ratings when controlling
for age and sex effects. In chi-square analysis, the chronic smokers had a higher frequency of
supertasters than did non-smokers (nontasters 18.62 vs. 22.1%; medium tasters 56.3 vs. 36.4%;
super tasters 25.1 vs. 41.6%, respectively; x2=10.2, p<0.01). Because of these PROP effects, the
non-smokers were matched on age, sex and PROP bitterness to test for quinine and NaCl
intensity differences between smokers and non-smokers.
The smokers reported quinine intensity on the tongue tip as between moderate and strong
and significantly less than NaCl intensity on the tongue tip, which averaged between strong and
very strong (28.19±2.41 vs. 41.03±2.58, respectively; t=6.24, p<.001). The distribution of these
tastants on the tongue tip were significantly skewed to higher intensity compared with age-, sexand PROP- matched controls (Figure One). For the whole mouth, the smokers reported quinine
and 1 M NaCl just above very strong and the .32 M NaCl between strong and very strong. In
comparison with the age-, sex- and PROP-matched nonsmokers, the smokers were not varied in
the distribution of intensity from whole mouth quinine and .32 M NaCl, but were significantly
skewed to higher intensity from 1 M NaCl (Figure One).
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Tongue Tip
2

 =14.7, p<.01

Whole Mouth
2

 =4.15, p=.126

2

 =1.11, p=77

Figure One: The distribution of taste intensity among chronic smokers (hatched bars) and
non-smokers (solid grey bars) following the NHANES taste testing protocol [53] with the
gLMS categories [52] on the x-axis and percent of smoker/non-smoker group on the y-axis
tested by the chi-square statistics

3.4.4 Taste function between menthol and non-menthol smokers
In analysis of covariance, the menthol and non-menthol smokers did not vary significantly
in average or distribution in intensity of tongue tip quinine or NaCl and whole mouth NaCl (1M,
.32 M) or quinine. However, the distribution of the average bitterness of 1mM and 3.2 mM
PROP was significantly different in menthol smokers than among non-menthol smokers
(D=0.31, p<0.05). Figure Two shows the distribution of nontasters (PROP<moderate), medium
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tasters (PROP between moderate and less than very strong), and supertasters (PROP≥ very
strong). There tended to be significantly fewer PROP nontasters but more supertasters among
the menthol smokers than non-menthol smokers (x2=5.21, p=0.074).
Figure Two: The distribution of propythiouracil taster status among chronic smokers who
smoke menthol (black bars) and non-menthol (shaded bars) cigarettes with the gLMS
categories53 on the x-axis and percent of smoker/non-smoker group on the y-axis tested by
the chi-square statistic.
50
45
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2=5.21, p=.074

Non-Menthol
Menthol

Percent of Group

35
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0
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3.4.5 Retronasal function
Overall, the flavor intensities heightened as participants rate plugged and then unplugged
jelly bean flavor intensities, with the biggest increase in sweetness intensity seen with the coffee
jelly bean flavor (mean +19.3) (Table Three). The flavor intensity ratings (unplugged) ranged
from between moderate and strong (chocolate mean 24.5) to close to strong/very strong (Coffee
mean 40.8). Cherry was the most liked jelly bean (mean liking of +35), and Tabasco was the
only mean disliked jelly bean (mean disliking of -26.63). The Tabasco jelly bean’s irritation
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intensity was rated as a mean of 31.64. There was no significant difference in any ratings by
menthol status.
Measured olfactory dysfunction (<13 correctly identified odors) was not associated with
depressed change in flavor intensity rating from plugged to unplugged, and was not associated
with depressed jelly bean flavor intensity ratings. There was no correlation between number of
smells identified correctly by olfactometry and either difference in flavor intensity rating plugged
to unplugged or flavor intensity rating alone (unplugged). However, those individuals with worse
dysfunction (<10 correctly identified odors) had significantly lower Tabasco flavor intensity
ratings than those without severe dysfunction (27.5 vs. 51.6 p=0.04) but no other jelly bean
flavors varied. This suggests that retronasal olfaction may not be affected by smoking as
orthonasal olfaction may be.
When examining jelly bean ratings by taster group (nontasters= <17, medium tasters 1753, supertasters >54 PROP intensity ratings), there was a trend in increasing flavor intensity
ratings for all jelly bean flavors between nontasters and supertasters, but this did not reach
significance.
Table Three: Change in jelly bean flavor intensity rating from unplugged rating to plugged
rating

3.4.6 Preferred electronic cigarette flavor
The most preferred electronic cigarette flavor was cherry (31.4%), followed by menthol
(30.4%) and tobacco (26.6%). Preferred electronic cigarette flavor did not significantly differ by
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sex, however did differ significantly by BMI class using fishers exact test. Those who were
obese most frequently rated cherry flavor as their most preferred flavor compared to normal
weight individuals (p= <0.005).
There was no association between measured olfactory dysfunction and preferred electronic
cigarette flavor. However, smokers who were supertasters based on PROP intensity classification
most frequently reported menthol electronic cigarette as their most preferred flavor, compared to
nontasters (40.6% vs. 23.5% respectively), although this did not reach statistical significance.
Favorite electronic cigarette flavor also differed significantly by menthol status. Menthol
smokers rated menthol the favorite flavor more frequently than non-menthol smokers (46.8% vs.
6.3%, p=<0.001) and non-menthol smokers rated tobacco the favorite flavor more frequently
(59.4% vs. 4.3%, p=<0.001).

3.5 Discussion
This study involved chemosensory phenotyping of a sample of chronic smokers. In
standardized chemosensory testing these chronic smokers showed 3 to 4-fold higher frequency of
measured olfactory dysfunction than that observed in the nationally-representative sample from
the NHANES6. Despite this high prevalence, the smokers were unaware of the dysfunction
unless it was at the level of severe hyposmia/anosmia as we have seen previously6,61. Retronasal
function did not seem to be altered by cigarette smoking as orthonasal olfaction was found to be.
The chronic smokers also reported heightened taste intensities from NaCl in comparison to nonsmoker controls, occurring not at concentrations where salt is primarily a taste (0.32 M), but at
levels of salt as an oral irritant (1 M)62 on the tongue tip as well as with whole mouth perception.
We did not find that smokers were more likely to be nontasters of PROP (a phenotypic marker of

- 59 -

genetic variation in taste) in comparison to controls. However, among the chronic smokers,
those who reported smoking menthol cigarettes were more likely to report elevated bitterness
from PROP. Electronic cigarette flavor preference did vary by menthol-status, with more
menthol smokers preferring menthol flavor and more non-menthol smokers preferring tobacco
flavor, and by BMI class, however there were no statistically significant differences between
preferred electronic cigarette flavor and olfactory function or taster groups.
Chronic exposure to smoking may cause direct damage to the peripheral nerve system to
explain our findings of elevated olfactory dysfunction among smokers. In animal models,
chronic exposure to smoking as well as ethanol is associated with olfactory epithelial neuron
death, undermining the regeneration capacity to maintain functional tissues63. Our rates of
olfactory dysfunction exceeded that in the NHANES study, which also utilized an odor
identification task but with a scratch and sniff procedure6,54. Odor identification requires the
ability to detect and correctly label an odor, which requires olfactory and cognitive processes10.
Loss of olfaction occurs with mild cognitive impairment10 and cognitive impairment has been
noted among smokers64. The present study utilized olfactometer generated-odors; the odor
intensities reported by the smokers were generally less than those reported by age and sexmatched non-smokers for most odors, including menthol54. Smoking also could have an indirect
relationship with olfactory dysfunction through other risk factors (e.g., head trauma, upper
respiratory tract infection, sinonasal disease)65,66. It is interesting that we did not observe the
usual sex difference in olfactory functioning with women exceeding men in functioning.
Females may suffer greater negative effects of smoking on olfactory dysfunction than males5.
Our data did not indicate that smokers have depressed taste perception, either in ability to
taste regionally on the tongue tip or with whole mouth experiences. Instead, relative to non-

- 60 -

smokers, the smokers here had a greater response to 1 M NaCl, an oral chemical irritant62, which
is consistent with the elevated oral irritation and pain seen in previous studies46,67. Other
components of somatosensation, however, do tend to be depressed in smokers including thermal
sensitivity43. The elevated intensity of NaCl irritation could not be explained by loss of taste as
seen with history of middle ear infections or taste nerve damage24. The regional differences in
taste and oral irritation could also reflect genetic variation68.
We did not note any alteration in retronasal function, and it did not associate with
orthonasal olfactory dysfunction via olfactometry. Studies have shown there are differences in
the perception and processing of orthonasal stimuli versus retronasal stimuli69, which may
account for these findings. One pathway may present as normal while the other can present with
dysfunction. Retronasal olfaction also interacts with the gustatory system69, which we did not
find to be depressed in smokers. In fact, because the taste functioning may be heightened in this
smoker sample, this may have countered any alterations to retronasal functioning.
Genetic variation in taste as indicated by the ability to taste the bitterness of PROP was
not different in our chronic smokers versus controls, but did vary by menthol cigarette
preference. We did not observe more PROP nontasters among our sample of chronic smokers,
which is inconsistent with previous findings of higher prevalence of nontasters among
smokers29,30. In fact, we observed higher PROP tasting ability among these smokers by the
intensity of PROP bitterness alone. Our testing employed aqueous solutions of concentrated
PROP, which is more intense than commercially available PTC strips. Frequently, PROP tasting
categories of nontaster, medium and supertaster are defined as the PROP to NaCl intensity ratio,
with nontasters having the lowest ratios (<0.4) and supertasters the highest (>1.2)55,70. However,
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our findings with NaCl suggest that this ratio could falsely shift the PROP/NaCl ratio toward
more nontasters and fewer supertasters.
Consistent with findings that female tasters by TAS2R38 receptor genotype were more
likely to smoke menthol cigarettes38, the present study found that, relative to non-menthol
smokers, menthol smokers were skewed toward reporting that PROP had greater bitterness. This
finding did not generalize to the bitterness of quinine, just for PROP, which may indicate a
stronger taste genetic component to this relationship. Menthol may improve the ability to tolerate
the unpleasant sensations of nicotine by providing a minty odor71 and oral and nasal cooling72,
especially for younger smokers and minorities73.
In regards to preferred electronic cigarette by the smokers in the study, significantly more
menthol smokers rated the menthol flavor as their most preferred than non menthol smokers.
Similarly, more supertasters rated the menthol electronic cigarette flavor as their most preferred.
This did not reach statistical significance, but may be due to the limited sample size. As previous
research notes, supertasters are more likely to smoke menthol cigarettes38, and these current
findings support this with other menthol flavored nicotine products as well. In addition, obese
individuals most frequently reported the cherry flavor electronic cigarette as their most preferred.
Research suggests obese individuals have a stronger attraction and preference to sweet than
normal weight individuals74.
This study had a number of limitations including a convenience sample of chronic
smokers and reliance on self-reported history. The taste protocol did not include all taste
qualities. Nonetheless, the sample was well characterized for smoking status and phenotyped
with measures that could be compared with the new NHANES self-reported and measured
olfactory functioning6,54. The taste testing also followed the NHANES protocol for future
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comparison to national norms, including aqueous tastants compared with matched controls.

3.6 Conclusion
In summary, this sample of chronic smokers showed elevated levels of olfactory
dysfunction but no evidence of taste dysfunction. Smokers had better sensitivity than specificity
of this olfaction issue, and it did not differ by menthol status. The smokers reported heightened
irritation from a concentrated NaCl solution compared to non-smokers. Menthol smokers were
more likely to be bitter tasters of PROP, the probe for genetic variation in taste. Similarly
menthol smokers were more likely to choose menthol flavored electronic cigarettes than nonmenthol smokers, and favorite flavor also varied by BMI. These findings allow for both future
insight into tobacco and nicotine product regulation and baseline data for interventions studies,
particularly those that might employ flavored nicotine replacement modalities, such as electronic
cigarettes.
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CHAPTER FOUR

CONCLUSION
4.1 Important Findings
This research was conducted to further examine the chemosensory abilities of cigarette
smokers. Utilizing a nationally-representative as well as a community-based sample, we were
able to use sophisticated characterization of smoking, and both self-report and objective
measures of chemosensory function. The research supported that chronic and dependent cigarette
smokers display olfactory dysfunction/alteration more frequently than do non-smokers, but do
not appear to display retronasal dysfunction or taste dysfunction. Instead, smokers reported
greater oral irritation by concentrated sodium chloride solutions, and menthol smokers
specifically reported heightened propylthiouracil (PROP) bitterness. In addition, electronic
cigarette flavor preference varied by menthol status, PROP taster classification, and weight.
These results add to the body of literature on chemosensory abilities of cigarette smokers, and
help clarify potential reasons for the conflicting findings. In addition, these findings indicated
another potential benefit for smoking cessation – improving chemosensory function – and
suggested that smoking is a modifiable risk factor that can help prevent and decrease the
prevalence of olfactory dysfunction. Finally, these results provided baseline characterization of
chronic smokers, allowing for comparison of function with cessation or switching to electronic
cigarettes, and can provide insight that can be used for nicotine production regulation.
Broader characterization of smoking status was crucial when examining who was most at
risk for a chemosensory alteration. Both chapters two and three involved characterization of
chronic and dependent smokers based on pack years and time to first cigarette of the day. In the
NHANES sample, classification of smoking status by current/former/never did not result in
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increased odds of an olfactory alteration in either current or former smokers compared to never
smokers. Smoking status required further classification, identifying chronic and dependent
smokers, defined as ≥10 pack year, <30 minute TTFC smokers, to be at increased risk of an
olfactory alteration compared to never/former smokers. Former chronic smokers (≥10 pack year)
also were at increased odds of self-reported olfactory alteration, compared to never smokers.
However, in the e-Cigarette sample of current chronic smokers, self-reported olfactory function
in smokers was not significantly different than the general population, despite having a greater
frequency of olfactory dysfunction than the general population. The scientific literature has
indicated that self-reported function has good sensitivity, but relatively poorer specificity,
particularly in recognizing less severe olfactory dysfunction. The chronic smoker sample
examined in chapter three most frequently showed measured hyposmia, which is less severe than
anosmia. Therefore, this thesis points to the need to use more than one measure of chemosensory
function, utilizing both self-report and objective measures when possible, to capture more
individuals who may suffer from olfactory dysfunction or alteration.
In addition to the finding that cigarette smokers may be at risk for olfactory alteration,
other health behaviors and issues associated with cigarette smoking influence the cigarette
smoking-olfactory alteration relationship. The NHANES analysis displayed that smokers who
were also heavy drinkers had the greatest odds of an olfactory alteration, even greater than being
a smoker alone. In addition, a portion of the relationship between smoking alone and in addition
to heavy drinking was explained through other olfactory-related pathologies, including sinonasal
problems, xerostomia, head/face injury, and history of a tonsillectomy. These results highlight
the importance of examining the complete relationship of risk factors and health behaviors to
fully capture those at increased risk for olfactory alterations. Those individuals with multiple
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addictions may be most at risk for chemosensory issues. Studies and clinical facilities must take
the time to probe complete behavioral and medical histories.
Furthermore, the e-Cigarette study analysis neither revealed taste dysfunction among
chronic smokers, nor showed that chronic smokers as more likely to be PROP nontasters as
compared to non-smokers. Chronic smokers reported heightened irritation from a concentrated
NaCl solution compared to non-smokers, not at the concentration of a tastant, but at the
concentration of an oral irritant. This heightened irritation may potentially affect diet quality and
quality of life, and these implications should be explored further. In addition, menthol-smokers
reported elevated PROP bitterness intensity compared to non-menthol smokers, indicating
genetic variations among this smoking sub-sample. These menthol/PROP supertasters, also
preferred menthol electronic cigarette flavor more frequently than non-menthol/PROP non-taster
smokers. This indicates that taste profiling may indicate those more likely to smoke menthol
cigarettes or flavored electronic cigarettes and associated health implications.
These studies suggest that chronic smokers (10+ PY smokers), who are also nicotine
dependent (<30 min TTFC), have differences in chemosensory function compared to nonsmokers, including increased frequency of olfactory dysfunction and heightened oral sensations.
Smoking must be characterized thoroughly in order to see these differences, pointing to a
potential reason why previous literature has found such conflicting results.

4.2 Implications for Future Research
Findings from this research help fill a gap in the literature, as smoking’s association with
chemosensory function has not been thoroughly examined utilizing sophisticated
characterization of smoking, specifically focusing on chronic and dependent smokers. We found
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that smokers do present with olfactory dysfunction and heighted oral irritation, which indicates
another benefit to smoking cessation that can be made aware to the public. Additionally, results
from these studies provide baseline data on the chemosensory abilities of cigarette smokers,
which can be used in the future to examine changes in these functions with cessation or
switching to electronic cigarettes. Future studies should also examine the impact these
heightened taste functions have on smoker’s diet quality, quality of life, and tendencies to smoke
other flavored nicotine products. Furthermore, because current treatment options for
chemosensory dysfunction are limited, prevention against these dysfunctions can be addressed
through modifiable risk factors. Both cessation or not beginning cigarette smoking and heavy
drinking can reduce the prevalence of chemosensory alterations.
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Supplemental Material
Unadjusted and adjusted odds ratios and 95% confidence intervals of risk factors
associated with self-reported smell alteration in U.S adults by smoking class
Table One: Current and former chronic smokers

Variables
Age
Sex (reference “female”)
Male
Race/Ethnicity (reference “white”)
Mexican American
Other Hispanic
Non-Hispanic Black
Non-Hispanic Asian
Other race
Marital Status (reference ”Married”)
Not Married
Education (reference ” ≥high school”)
Less than high school
IPR (reference “>1”)
IPR ≤ 1
Sinonasal problems (reference ”no”)
Yes
Xerostomia (reference ”no”)
Yes
Head/Face Injury (reference ”no”)
Yes
Tonsils Removed (reference “no”)
Yes
Multiple Ear Infections (reference “no”)
Yes
Self-rated Health (reference “excellent, very
good, good”)
Fair or poor
Heavy Drinking (reference “no”)
Yes

Self-reported smell alteration
Unadjusted
Adjusted
OR
95% CI
OR
95% CI
1.007
1.001–1.014
1.00
0.99-1.008
1.009

0.90–1.13

0.99

0.85-1.17

0.90

0.73–1.1

0.93

0.75–1.15

0.80

0.65–0.98

0.85

0.67-1.09

0.50
1.48

0.37-0.68
0.85–2.57

0.76

0.53-1.09

1.2

1.07–1.35

1.02

0.87-1.20

1.12

0.93–1.37

1.40

1.18–1.64

1.23

1.00-1.50

2.21

1.86–2.63

1.75

1.38-2.22

2.40

2.04–2.83

1.80

1.52-2.13

1.56

1.28–1.88

1.30

1.04-1.63

1.36

1.12–1.66

1.29

1.05-1.60

1.52

1.22–1.90

1.17

0.91-1.50

1.63

1.36–1.95

1.23

1.02-1.48

1.76

1.35–2.31

1.38

1.00-1.91

1.16
1.75

0.86-1.56
1.45-2.12

0.97
1.36

0.71-1.34
1.06-1.74

Smoking Status (reference “never smoker”)
<10 PY Light Smokers
Chronic Smokers
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Table Two: Chronic smokers stratified by current and former smokers

Variables
Age
Sex (reference “female”)
Male
Race/Ethnicity (reference “white”)
Mexican American
Other Hispanic
Non-Hispanic Black
Non-Hispanic Asian
Other race
Marital Status (reference ”Married”)
Not Married
Education (reference ” ≥high school”)
Less than high school
IPR (reference “>1”)
IPR ≤ 1
Sinonasal problems (reference ”no”)
Yes
Xerostomia (reference ”no”)
Yes
Head/Face Injury (reference ”no”)
Yes
Tonsils Removed (reference “no”)
Yes
Multiple Ear Infections (reference “no”)
Yes
Self-rated Health (reference “excellent, very
good, good”)
Fair or poor
Heavy Drinking (reference “no”)
Yes
Smoking Status (reference “never smoker”)
<10 PY Light Smokers
Current Chronic Smokers
Former Chronic Smokers

Self-reported smell alteration
Unadjusted
Adjusted
OR
95% CI
OR
95% CI
1.007
1.001–1.014
1.00
0.99-1.007
1.009

0.90–1.13

0.99

0.84-1.17

0.90

0.73–1.1

0.93

0.75–1.15

0.80

0.65–0.98

0.85

0.67-1.09

0.50
1.48

0.37-0.68
0.85–2.57

0.76

0.53-1.09

1.2

1.07–1.35

1.03

0.87-1.22

1.12

0.93–1.37

1.40

1.18–1.64

1.23

1.02-1.50

2.21

1.86–2.63

1.75

1.38-2.22

2.40

2.04–2.83

1.80

1.52-2.13

1.56

1.28–1.88

1.30

1.04-1.63

1.36

1.12–1.66

1.29

1.05-1.60

1.52

1.22–1.90

1.17

0.91-1.50

1.63

1.36–1.95

1.23

1.02-1.48

1.76

1.35–2.31

1.38

1.00-1.91

1.16
1.75
1.72

0.86-1.56
1.34-2.37
1.39-2.12

0.97
1.29
1.42

0.71-1.33
0.93-1.80
1.09-1.84
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Table Three: Current chronic high dependent smokers

Variables
Age
Sex (reference “female”)
Male
Race/Ethnicity (reference “white”)
Mexican American

Self-reported smell alteration
Unadjusted
Adjusted
OR
95% CI
OR
95% CI
1.007
1.001–1.014
1.002
0.99-1.01
1.01

0.85-1.19

0.65–0.98

0.86

0.67-1.09

0.50
1.48

0.37-0.68
0.85–2.57

0.78

0.55-1.09

1.2

1.07–1.35

1.02

0.85-1.21

1.12

0.93–1.37

1.40

1.18–1.64

1.22

1.00-1.50

2.21

1.86–2.63

1.80

1.43-2.26

2.40

2.04–2.83

1.75

1.45-2.11

1.56

1.28–1.88

1.35

1.08-1.68

1.36

1.12–1.66

1.28

1.03-1.59

1.52

1.22–1.90

1.16

0.91-1.48

1.63

1.36–1.95

1.24

1.03-1.51

1.76

1.35–2.31

1.44

1.03-2.00

Light Smokers (<10 PY/>30 min TTFC)

1.08

0.84-1.38

0.90

0.66-1.20

Current Chronic High Dependent Smoker

1.82

1.38-2.41

1.41

1.01-1.99

Other Hispanic
Non-Hispanic Black
Non-Hispanic Asian
Other race
Marital Status (reference ”Married”)
Not Married
Education (reference ” ≥high school”)
Less than high school
IPR (reference “>1”)
IPR ≤ 1
Sinonasal problems (reference ”no”)
Yes
Xerostomia (reference ”no”)
Yes
Head/Face Injury (reference ”no”)
Yes
Tonsils Removed (reference “no”)
Yes
Multiple Ear Infections (reference “no”)
Yes
Self-rated Health (reference “excellent, very
good, good”)
Fair or poor
Heavy Drinking (reference “no”)
Yes
Smoking Status (reference “never/former
smoker”)

1.009

0.90–1.13

0.90

0.73–1.1

0.93

0.75–1.15

0.80
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Table Four: Chronic Active Smokers
Self-reported smell alteration
Unadjusted
Adjusted
Variables
Age
Sex (reference “female”)
Male
Race/Ethnicity (reference “white”)
Mexican American

OR
1.007

95% CI
1.001–1.014

OR
1.005

95% CI
0.99-1.02

1.009

0.90–1.13

0.97

0.74-1.27

0.90

0.73–1.1

0.93

0.75–1.15

0.80

0.65–0.98

0.90

0.63-1.27

0.50
1.48

0.37-0.68
0.85–2.57

0.84

0.57-1.24

1.2

1.07–1.35

1.08

0.88-1.31

1.12

0.93–1.37

1.40

1.18–1.64

1.48

1.13-1.96

2.21

1.86–2.63

1.82

1.33-2.49

2.40

2.04–2.83

1.53

1.12-2.09

1.56

1.28–1.88

1.40

0.92-2.14

1.36

1.12–1.66

1.30

0.93-1.82

1.52

1.22–1.90

1.13

0.78-1.64

1.63

1.36–1.95

1.22

0.90-1.67

1.76

1.35–2.31

1.57

1.03-2.38

Light smokers(<10 cotinine/<10 PY)

0.97

0.68-1.37

0.73

0.46-1.17

Chronic Active Smokers

1.56

1.00-2.49

1.22

0.72-2.05

Other Hispanic
Non-Hispanic Black
Non-Hispanic Asian
Other race
Marital Status (reference ”Married”)
Not Married
Education (reference ” ≥high school ”)
Less than high school
IPR (reference “>1”)
IPR ≤ 1
Sinonasal problems (reference ”no”)
Yes
Xerostomia (reference ”no”)
Yes
Head/Face Injury (reference ”no”)
Yes
Tonsils Removed (reference “no”)
Yes
Multiple Ear Infections (reference “no”)
Yes
Self-rated Health (reference “excellent, very
good, good”)
Fair or poor
Heavy Drinking (reference “no”)
Yes
Smoking Status (reference “never/former
smoker”)
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Table Five: High Dependent Active Smokers

Variables
Age
Sex (reference “female”)
Male
Race/Ethnicity (reference “white”)
Mexican American
Other Hispanic
Non-Hispanic Black
Non-Hispanic Asian
Other race
Marital Status (reference ”Married”)
Not Married
Education (reference ” ≥high school”)
Less than high school
IPR (reference “>1”)
IPR ≤ 1
Sinonasal problems (reference ”no”)
Yes
Xerostomia (reference ”no”)
Yes
Head/Face Injury (reference ”no”)
Yes
Tonsils Removed (reference “no”)
Yes
Multiple Ear Infections (reference “no”)
Yes
Self-rated Health (reference “excellent, very
good, good”)
Fair or poor
Heavy Drinking (reference “no”)
Yes
Smoking Status (reference “never/former
smoker”)
Light smokers(<10 cotinine/>30 min
TTFC)
High Dependent Active Smokers

Self-reported smell alteration
Unadjusted
Adjusted
OR
95% CI
OR
95% CI
1.007
1.001–1.014
1.004
0.99-1.02
1.009

0.90–1.13

0.98

0.71-1.35

0.90

0.73–1.1

0.93

0.75–1.15

0.80
0.50
1.48

0.65–0.98
0.37-0.68
0.85–2.57

0.98
0.85

0.69-1.38
0.58-1.25

1.2

1.07–1.35

1.02

0.83-1.25

1.12

0.93–1.37

1.40

1.18–1.64

1.47

1.10-1.98

2.21

1.86–2.63

1.84

1.34-2.52

2.40

2.04–2.83

1.44

1.06-1.96

1.56

1.28–1.88

1.45

0.95-2.22

1.36

1.12–1.66

1.36

1.00-1.85

1.52

1.22–1.90

1.09

0.76-1.57

1.63

1.36–1.95

1.27

0.92-1.75

1.76

1.35–2.31

1.44

0.94-2.19

1.00

0.68-1.48

0.76

0.51-1.15

1.62

1.00-2.62

1.22

0.77-1.93
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Table Six: High Dependent Smoker-Heavy Drinker

Variables
Age
Sex (reference “female”)
Male
Race/Ethnicity (reference “white”)
Mexican American

Self-reported smell alteration
Unadjusted
Adjusted
OR
95% CI
OR
95% CI
1.007
1.001–1.014
1.003
0.99–1.01
1.05

0.88–1.26

0.65–0.98
0.37-0.68
0.85–2.57

0.82
0.78

0.62-1.07
0.55-1.11

1.2

1.07–1.35

1.02

0.85-1.22

1.12

0.93–1.37

1.40

1.18–1.64

1.18

0.96-1.45

2.21

1.86–2.63

1.81

1.42–2.30

2.40

2.04–2.83

1.74

1.46–2.09

1.56

1.28–1.88

1.38

1.09–1.76

1.36

1.12–1.66

1.31

1.07-1.60

1.52

1.22–1.90

1.09

0.85-1.40

1.63

1.36–1.95

1.27

1.00-1.62

Dependent smoker, non-drinker

1.45

1.06-1.99

1.30

0.92-1.83

Non-smoker, heavy drinker

1.75

1.21-2.53

1.45

0.93-2.26

Dependent Smoker-heavy drinker

2.34

1.55-3.54

1.96

1.20-3.19

Other Hispanic
Non-Hispanic Black
Non-Hispanic Asian
Other race
Marital Status (reference ”Married”)
Not Married
Education (reference ” ≥high school”)
Less than high school
IPR (reference “>1”)
IPR ≤ 1
Sinonasal problems (reference ”no”)
Yes
Xerostomia (reference ”no”)
Yes
Head/Face Injury (reference ”no”)
Yes
Tonsils Removed (reference “no”)
Yes
Multiple Ear Infections (reference “no”)
Yes
Self-rated Health (reference “excellent, very
good, good”)
Fair or poor
Smokers and Drinkers (reference
“never/former smoker, non-heavy drinker”)

1.009

0.90–1.13

0.90

0.73–1.1

0.93

0.75–1.15

0.80
0.50
1.48
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